<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">EMBO Mol Med</journal-id>
<journal-id journal-id-type="iso-abbrev">EMBO Mol Med</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)1757-4684</journal-id>
<journal-id journal-id-type="publisher-id">EMMM</journal-id>
<journal-id journal-id-type="hwp">embomm</journal-id>
<journal-title-group>
<journal-title>EMBO Molecular Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1757-4676</issn>
<issn pub-type="epub">1757-4684</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26671989</article-id>
<article-id pub-id-type="pmc">4718157</article-id>
<article-id pub-id-type="doi">10.15252/emmm.201505677</article-id>
<article-id pub-id-type="publisher-id">EMMM201505677</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Research Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Molecular cause and functional impact of altered synaptic lipid signaling due to a <italic>prg‐1</italic> gene <styled-content style="fixed-case">SNP</styled-content>
</article-title>
<alt-title alt-title-type="left-running-head">Johannes Vogt <italic>et al</italic></alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" id="emmm201505677-cr-0001">
<name>
<surname>Vogt</surname>
<given-names>Johannes</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="author-note" rid="emmm201505677-note-0001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0002">
<name>
<surname>Yang</surname>
<given-names>Jenq‐Wei</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="author-note" rid="emmm201505677-note-0001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0003">
<name>
<surname>Mobascher</surname>
<given-names>Arian</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0003">
<sup>3</sup>
</xref>
<xref ref-type="author-note" rid="emmm201505677-note-0001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0004">
<name>
<surname>Cheng</surname>
<given-names>Jin</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0005">
<name>
<surname>Li</surname>
<given-names>Yunbo</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0006">
<name>
<surname>Liu</surname>
<given-names>Xingfeng</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0007">
<name>
<surname>Baumgart</surname>
<given-names>Jan</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0008">
<name>
<surname>Thalman</surname>
<given-names>Carine</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0009">
<name>
<surname>Kirischuk</surname>
<given-names>Sergei</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0010">
<name>
<surname>Unichenko</surname>
<given-names>Petr</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0011">
<name>
<surname>Horta</surname>
<given-names>Guilherme</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0012">
<name>
<surname>Radyushkin</surname>
<given-names>Konstantin</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0013">
<name>
<surname>Stroh</surname>
<given-names>Albrecht</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0014">
<name>
<surname>Richers</surname>
<given-names>Sebastian</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0015">
<name>
<surname>Sahragard</surname>
<given-names>Nassim</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0016">
<name>
<surname>Distler</surname>
<given-names>Ute</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0004">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="emmm201505677-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0017">
<name>
<surname>Tenzer</surname>
<given-names>Stefan</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0018">
<name>
<surname>Qiao</surname>
<given-names>Lianyong</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0019">
<name>
<surname>Lieb</surname>
<given-names>Klaus</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0020">
<name>
<surname>Tüscher</surname>
<given-names>Oliver</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0021">
<name>
<surname>Binder</surname>
<given-names>Harald</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0006">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0022">
<name>
<surname>Ferreiros</surname>
<given-names>Nerea</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0007">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0023">
<name>
<surname>Tegeder</surname>
<given-names>Irmgard</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0007">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0024">
<name>
<surname>Morris</surname>
<given-names>Andrew J</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0008">
<sup>8</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0025">
<name>
<surname>Gropa</surname>
<given-names>Sergiu</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0009">
<sup>9</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0026">
<name>
<surname>Nürnberg</surname>
<given-names>Peter</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0010">
<sup>10</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0027">
<name>
<surname>Toliat</surname>
<given-names>Mohammad R</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0010">
<sup>10</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0028">
<name>
<surname>Winterer</surname>
<given-names>Georg</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0010">
<sup>10</sup>
</xref>
<xref ref-type="author-note" rid="emmm201505677-note-0001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0029">
<name>
<surname>Luhmann</surname>
<given-names>Heiko J</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="author-note" rid="emmm201505677-note-0001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="emmm201505677-cr-0030">
<name>
<surname>Huai</surname>
<given-names>Jisen</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="author-note" rid="emmm201505677-note-0001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="emmm201505677-cr-0031">
<name>
<surname>Nitsch</surname>
<given-names>Robert</given-names>
</name>
<xref ref-type="aff" rid="emmm201505677-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="author-note" rid="emmm201505677-note-0001">
<sup>†</sup>
</xref>
</contrib>
</contrib-group>
<aff id="emmm201505677-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Institute for Microscopic Anatomy and Neurobiology</named-content>
<named-content content-type="organisation-division">University Medical Center</named-content>
<institution>Johannes Gutenberg‐University</institution>
<named-content content-type="city">Mainz</named-content>
<country country="DE">Germany</country>
</aff>
<aff id="emmm201505677-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Institute for Physiology and Pathophysiology</named-content>
<named-content content-type="organisation-division">University Medical Center</named-content>
<institution>Johannes Gutenberg‐University</institution>
<named-content content-type="city">Mainz</named-content>
<country country="DE">Germany</country>
</aff>
<aff id="emmm201505677-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Psychiatry and Psychotherapy</named-content>
<named-content content-type="organisation-division">University Medical Center</named-content>
<institution>Johannes Gutenberg‐University Mainz</institution>
<named-content content-type="city">Mainz</named-content>
<country country="DE">Germany</country>
</aff>
<aff id="emmm201505677-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Focus Program Translational Neuroscience (FTN)</named-content>
<named-content content-type="organisation-division">University Medical Center</named-content>
<institution>Johannes Gutenberg‐University</institution>
<named-content content-type="city">Mainz</named-content>
<country country="DE">Germany</country>
</aff>
<aff id="emmm201505677-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Institute for Immunology</named-content>
<named-content content-type="organisation-division">University Medical Center</named-content>
<institution>Johannes Gutenberg‐University Mainz</institution>
<named-content content-type="city">Mainz</named-content>
<country country="DE">Germany</country>
</aff>
<aff id="emmm201505677-aff-0006">
<label>
<sup>6</sup>
</label>
<named-content content-type="organisation-division">Institute of Medical Biostatistics, Epidemiology and Informatics</named-content>
<named-content content-type="organisation-division">University Medical Center</named-content>
<institution>Johannes Gutenberg‐University Mainz</institution>
<named-content content-type="city">Mainz</named-content>
<country country="DE">Germany</country>
</aff>
<aff id="emmm201505677-aff-0007">
<label>
<sup>7</sup>
</label>
<institution>Institute of Clinical Pharmacology Goethe‐University Hospital</institution>
<named-content content-type="city">Frankfurt am Main</named-content>
<country country="DE">Germany</country>
</aff>
<aff id="emmm201505677-aff-0008">
<label>
<sup>8</sup>
</label>
<named-content content-type="organisation-division">Division of Cardiovascular Medicine</named-content>
<named-content content-type="organisation-division">Gill Heart Institute</named-content>
<institution>University of Kentucky</institution>
<named-content content-type="city">Lexington</named-content>
<named-content content-type="country-part">KY</named-content>
<country country="US">USA</country>
</aff>
<aff id="emmm201505677-aff-0009">
<label>
<sup>9</sup>
</label>
<named-content content-type="organisation-division">Department of Neurology</named-content>
<named-content content-type="organisation-division">University Medical Center</named-content>
<institution>Johannes Gutenberg‐University Mainz</institution>
<named-content content-type="city">Mainz</named-content>
<country country="DE">Germany</country>
</aff>
<aff id="emmm201505677-aff-0010">
<label>
<sup>10</sup>
</label>
<named-content content-type="organisation-division">Cologne Center for Genomics (CCG)</named-content>
<institution>University of Cologne</institution>
<named-content content-type="city">Cologne</named-content>
<country country="DE">Germany</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label>
Corresponding author. Tel: +49 6131 17 8091/8072; E‐mail: <email>johannes.vogt@unimedizin-mainz.de</email><break></break>
Corresponding author. Tel: +49 6131 17 8091/8072; E‐mail: <email>robert.nitsch@unimedizin-mainz.de</email><break></break></corresp>
<fn fn-type="equal" id="emmm201505677-note-0001">
<label>†</label>
<p>These authors contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>12</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2016</year>
</pub-date>
<volume>8</volume>
<issue>1</issue>
<issue-id pub-id-type="doi">10.1002/emmm.v8.1</issue-id>
<fpage>25</fpage>
<lpage>38</lpage>
<history>
<date date-type="received">
<day>25</day>
<month>7</month>
<year>2015</year>
</date>
<date date-type="rev-recd">
<day>12</day>
<month>11</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>11</month>
<year>2015</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2016 EMBO <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2015 The Authors. Published under the terms of the CC BY 4.0 license</copyright-statement>
<license license-type="creativeCommonsBy">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:EMMM-8-25.pdf" xlink:type="simple"></self-uri>
<abstract abstract-type="main" id="emmm201505677-abs-0001">
<title>Abstract</title>
<p>Loss of plasticity‐related gene 1 (<styled-content style="fixed-case">PRG</styled-content>‐1), which regulates synaptic phospholipid signaling, leads to hyperexcitability via increased glutamate release altering excitation/inhibition (E/I) balance in cortical networks. A recently reported <styled-content style="fixed-case">SNP</styled-content> in <italic>prg‐1</italic> (R345T/mut<styled-content style="fixed-case">PRG</styled-content>‐1) affects ~5 million European and <styled-content style="fixed-case">US</styled-content> citizens in a monoallelic variant. Our studies show that this mutation leads to a loss‐of‐<styled-content style="fixed-case">PRG</styled-content>‐1 function at the synapse due to its inability to control lysophosphatidic acid (LPA) levels via a cellular uptake mechanism which appears to depend on proper glycosylation altered by this <styled-content style="fixed-case">SNP</styled-content>. <styled-content style="fixed-case">PRG</styled-content>‐1<sup>+/−</sup> mice, which are animal correlates of human <styled-content style="fixed-case">PRG</styled-content>‐1<sup>+/mut</sup> carriers, showed an altered cortical network function and stress‐related behavioral changes indicating altered resilience against psychiatric disorders. These could be reversed by modulation of phospholipid signaling via pharmacological inhibition of the <styled-content style="fixed-case">LPA</styled-content>‐synthesizing molecule autotaxin. In line, <styled-content style="fixed-case">EEG</styled-content> recordings in a human population‐based cohort revealed an E/I balance shift in monoallelic mut<styled-content style="fixed-case">PRG</styled-content>‐1 carriers and an impaired sensory gating, which is regarded as an endophenotype of stress‐related mental disorders. Intervention into bioactive lipid signaling is thus a promising strategy to interfere with glutamate‐dependent symptoms in psychiatric diseases.</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="emmm201505677-kwd-0001">bioactive phospholipids</kwd>
<kwd id="emmm201505677-kwd-0002">cortical network</kwd>
<kwd id="emmm201505677-kwd-0003"><styled-content style="fixed-case">PRG</styled-content>‐1</kwd>
<kwd id="emmm201505677-kwd-0004">psychiatric disorders</kwd>
<kwd id="emmm201505677-kwd-0005">synapse</kwd>
</kwd-group>
<kwd-group kwd-group-type="subject-categories">
<title>Subject Categories</title>
<kwd>Genetics, Gene Therapy &amp; Genetic Disease</kwd>
<kwd>Neuroscience</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>European Research Council (ERC‐AG “LiPsyD”)</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>Deutsche Forschungsgemeinschaft (DFG)</funding-source>
<award-id>CRC1080</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="14"></page-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>emmm201505677</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>January 2016</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.7.5 mode:remove_FC converted:19.01.2016</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="emmm201505677-cit-1001" publication-type="journal">
<source/>EMBO Mol Med (<year>2016</year>) <volume>8</volume>: <fpage>25</fpage>–<lpage>38</lpage>
</mixed-citation>
</p>
</notes>
<notes>
<fn-group id="emmm201505677-ntgp-0001">
<fn fn-type="associated-article" id="emmm201505677-note-0002">
<p>See also: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.15252/emmm.201505749">B Stutz &amp; TL Horvath</ext-link> (January 2016)</p>
</fn>
</fn-group>
</notes>
</front>
<body>
<sec id="emmm201505677-sec-0001">
<title>Introduction</title>
<p>Accurate synaptic transmission is a fundamental requirement for normal brain function (Turrigiano, <xref ref-type="ref" rid="emmm201505677-bib-0048">2011</xref>), and signaling alterations at the excitatory synapse have been related to psychiatric disorders such as schizophrenia (Harrison &amp; Weinberger, <xref ref-type="ref" rid="emmm201505677-bib-0017">2005</xref>; Coyle, <xref ref-type="ref" rid="emmm201505677-bib-0010">2006</xref>; Belforte <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0003">2010</xref>). Recent research shows that bioactive lipid signaling and protein–lipid interaction play major roles in all steps of endo‐ and exocytosis processes, including synaptic vesicle cycling (Di Paolo <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0013">2004</xref>). Plasticity‐related gene 1 (PRG‐1, also assigned as LPPR4), a neuron‐specific molecule in the brain, is an important postsynaptic control element of this pathway (Trimbuch <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0044">2009</xref>). Previously, we demonstrated that the absence of PRG‐1 (Brauer <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0004">2003</xref>), which is involved in synaptic phospholipid signaling, leads to hippocampal hyperexcitability via increased glutamate release at the synapse (Trimbuch <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0044">2009</xref>). Recently, a single nucleotide polymorphism (SNP, rs138327459, NHLBI Exome Sequencing Project <ext-link ext-link-type="uri" xlink:href="https://esp.gs.washington.edu/drupal/">https://esp.gs.washington.edu/drupal/</ext-link>) was detected in humans resulting in an arginine (R) to threonine (T) exchange at position 345 of the amino acid chain (mouse homolog located at position 346). Our electrophysiological studies using re‐expression of PRG‐1<sup>R346T</sup> in PRG‐1<sup>−/−</sup> mice by <italic>in utero</italic> electroporation revealed that this mutation results in a loss‐of‐PRG‐1 function at the synapse. On a molecular level, we could show that PRG‐1<sup>R346T</sup> lacked the ability to support uptake of lysophosphatidic acid (LPA) into intracellular compartments due to altered O‐glycosylation of S347 next to the SNP site, while in‐depth quantitative analysis revealed no role for serine phosphorylation at this position. PRG‐1 heterozygous mice which are an animal correlate for human monoallelic PRG‐1<sup>+/mut</sup> carriers showed altered cortical information processing and stress‐related behavioral deficits indicative for mental disorders. Using specific inhibitors of phospholipid synthesis, we could show that modulation of bioactive phospholipid levels upstream of PRG‐1 reverted cortical network function and behavior toward wild‐type (wt) levels. In line with experimental data, electrophysiological assessment using the P50 sensory gating auditory paradigm (which corresponds to the pre‐pulse inhibition (PPI) tested in mice) revealed an altered sensory gating in monoallelic R345T PRG‐1 carriers which were identified among 1,811 human volunteers in a population‐based cohort. Since similar alterations of cortical excitability and sensory gating have been described as an endophenotype of schizophrenia and stress‐related disorders (Turetsky <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0047">2007</xref>; Javitt <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0023">2008</xref>), our results indicate a novel therapeutic strategy targeting synaptic bioactive lipid signaling in altered cortical information processing related to mental disorders.</p>
</sec>
<sec id="emmm201505677-sec-0002">
<title>Results</title>
<sec id="emmm201505677-sec-0003">
<title>PRG‐1<sup>R346T</sup> is a loss‐of‐function mutation</title>
<p>PRG‐1 was shown to be involved in internalization of lysophosphatidic acid (LPA) to intracellular postsynaptic compartments (Trimbuch <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0044">2009</xref>), thereby controlling LPA levels in the synaptic cleft. To understand the molecular consequences of the human SNP resulting in arginine (R) to threonine (T) exchange at position 345 in the amino acid chain of PRG‐1, we established HEK cell lines with stable expression of the mouse homolog of this SNP, PRG‐1<sup>R346T</sup>, and found similar membrane localization when compared to wild‐type PRG‐1 (wtPRG‐1, Fig <xref ref-type="fig" rid="emmm201505677-fig-0001">1</xref>A). After application of fluorescence labeled LPA (TopFluor (TF)‐LPA) and removal of surface bound TF‐LPA using 0.001% SDS, PRG‐1<sup>R346T</sup>‐expressing cells displayed a lower fluorescence signal in intracellular compartments (Fig <xref ref-type="fig" rid="emmm201505677-fig-0001">1</xref>B). This finding was quantified by FACS analysis (example shown in Fig <xref ref-type="fig" rid="emmm201505677-fig-0001">1</xref>C) revealing a significantly reduced capacity of PRG‐1<sup>R346T</sup>‐expressing cells to internalize TF‐LPA when compared to wtPRG‐1 (Fig <xref ref-type="fig" rid="emmm201505677-fig-0001">1</xref>D). To unambiguously prove the internalization of LPA, we applied a chemically modified, unnatural LPA (C17‐LPA) on wtPRG‐1‐expressing cells which showed a statistically significant internalization of C17‐LPA (Fig <xref ref-type="fig" rid="emmm201505677-fig-0001">1</xref>E) and the intracellular presence of its metabolite C17‐MAG (Fig <xref ref-type="fig" rid="emmm201505677-fig-0001">1</xref>F) when compared to HEK cells which lack any PRG‐1 expression. In line with previous results, PRG‐1<sup>R346T</sup>‐expressing cells did not show a significant increase of intracellular C17 LPA nor of its metabolite C17‐MAG providing further evidence that PRG‐1<sup>R346T</sup> lacks the capacity to mediate internalization of LPA into cells (Fig <xref ref-type="fig" rid="emmm201505677-fig-0001">1</xref>E and F).</p>
<fig fig-type="Figure" id="emmm201505677-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<title>
<styled-content style="fixed-case">PRG</styled-content>‐1<sup>R346T</sup>: loss‐of‐function mutation reduced <styled-content style="fixed-case">LPA</styled-content> internalization due to altered O‐glycosylation</title>
<p>
<list id="emmm201505677-list-0002" list-type="simple"><list-item><label>A</label><p>
<styled-content style="fixed-case">PRG</styled-content>‐1 and <styled-content style="fixed-case">PRG</styled-content>‐1<sup>R346T</sup> are expressed on <styled-content style="fixed-case">HEK</styled-content>293 cell membranes.</p></list-item><list-item><label>B</label><p>Conventional fluorescence images of transfected and TopFluor (<styled-content style="fixed-case">TF</styled-content>)‐<styled-content style="fixed-case">LPA</styled-content>‐stimulated cells after washing with 0.001% <styled-content style="fixed-case">SDS</styled-content>. Scale bar: 10 μm.</p></list-item><list-item><label>C, D</label><p>
<styled-content style="fixed-case">FACS</styled-content> analysis of internalized <styled-content style="fixed-case">TF</styled-content>‐<styled-content style="fixed-case">LPA</styled-content> of <styled-content style="fixed-case">PRG</styled-content>‐1‐ and <styled-content style="fixed-case">PRG</styled-content>‐1<sup>R346T</sup>‐transfected cells (<italic>n </italic>=<italic> </italic>7 each, **<italic>P </italic>=<italic> </italic>0.0015; <italic>t</italic>‐test).</p></list-item><list-item><label>E, F</label><p>Incubation with C‐17 <styled-content style="fixed-case">LPA</styled-content> and subsequent washing as described above, led to a significant increase of <styled-content style="fixed-case">TF</styled-content>‐<styled-content style="fixed-case">LPA</styled-content> in <styled-content style="fixed-case">PRG</styled-content>‐1‐expressing cells but not in <styled-content style="fixed-case">PRG</styled-content>‐1<sup>R346T</sup>‐expressing cells. In line, C‐17 <styled-content style="fixed-case">MG</styled-content>, a degradation product of C‐17 <styled-content style="fixed-case">LPA</styled-content>, was significantly increased in <styled-content style="fixed-case">PRG</styled-content>‐1‐expressing cells but not in control or <styled-content style="fixed-case">PRG</styled-content>‐1<sup>R346T</sup>‐expressing cells (<italic>n </italic>=<italic> </italic>4 each; Kruskal–Wallis test (for C‐17 <styled-content style="fixed-case">LPA </styled-content>
<italic>P </italic>=<italic> </italic>0.0066; for C‐17 <styled-content style="fixed-case">MAG </styled-content>
<italic>P </italic>=<italic> </italic>0.0048) with Dunn's multiple comparison test, *<italic>P</italic> &lt; 0.05 for C‐17 <styled-content style="fixed-case">LPA</styled-content> and C‐17 <styled-content style="fixed-case">MAG</styled-content>).</p></list-item><list-item><label>G</label><p>Quantitative assessment of S347 phosphorylation using isotopically labeled peptides and mass spectrometry of purified wild‐type <styled-content style="fixed-case">PRG</styled-content>‐1 and <styled-content style="fixed-case">PRG</styled-content>‐1<sup>R346T</sup> from stable transfected <styled-content style="fixed-case">HEK</styled-content>293 cells revealed low total phosphorylation levels for both protein variants (<italic>n </italic>=<italic> </italic>3 measurements).</p></list-item><list-item><label>H</label><p>
<styled-content style="fixed-case">TF</styled-content>‐<styled-content style="fixed-case">LPA</styled-content> uptake as analyzed by <styled-content style="fixed-case">FACS</styled-content> was significantly decreased in S347A and S347D mutant <styled-content style="fixed-case">PRG</styled-content>‐1 (<italic>n </italic>=<italic> </italic>12 per condition, ***<italic>P</italic> &lt; 0.0001; one‐way <styled-content style="fixed-case">ANOVA</styled-content> with Bonferroni's multiple comparison test).</p></list-item><list-item><label>I</label><p>Western blot (<styled-content style="fixed-case">WB</styled-content>) of <styled-content style="fixed-case">IP</styled-content> using a specific <styled-content style="fixed-case">PRG</styled-content>‐1 antibody revealed decreased levels of O‐Glc<styled-content style="fixed-case">NA</styled-content>c in <styled-content style="fixed-case">PRG</styled-content>‐1<sup>R346T</sup> when compared to wild‐type <styled-content style="fixed-case">PRG</styled-content>‐1.</p></list-item><list-item><label>J</label><p>Densitometric analysis of <italic>n </italic>=<italic> </italic>7 <styled-content style="fixed-case">WB</styled-content> from <styled-content style="fixed-case">IP</styled-content> of <styled-content style="fixed-case">PRG</styled-content>‐1‐ and <styled-content style="fixed-case">PRG</styled-content>‐1<sup>R346T</sup>‐expressing cells revealed a significantly decreased O‐Glc<styled-content style="fixed-case">NA</styled-content>c amount in <styled-content style="fixed-case">PRG</styled-content>‐1<sup>R346T</sup> (unpaired <italic>t</italic>‐test, *<italic>P </italic>=<italic> </italic>0.0107).</p></list-item></list>Data information: All experiments were done in parallel. Bar diagrams represent mean ± SEM. *<italic>P </italic>&lt;<italic> </italic>0.05, **<italic>P </italic>&lt;<italic> </italic>0.01, ***<italic>P </italic>&lt;<italic> </italic>0.001.</p>
</caption>
<graphic id="nlm-graphic-5" xlink:href="EMMM-8-25-g002"></graphic>
</fig>
</sec>
<sec id="emmm201505677-sec-0004">
<title>PRG‐1<sup>R346T</sup> alters O‐glycosylation, but not phosphorylation of neighboring S347</title>
<p>Since PRG‐1<sup>R346T</sup> was properly expressed at the membrane, we hypothesized a posttranslational modification being involved in the loss of function in TF‐LPA internalization. Interestingly, the SNP changing R345 (arginine) to 345T (threonine) is located in close proximity to a frequently reported phosphorylation site (Munton <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0033">2007</xref>; Trinidad <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0045">2008</xref>; Huttlin <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0021">2010</xref>; Wisniewski <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0050">2010</xref>; Goswami <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0016">2012</xref>). Therefore, we addressed the question to what extent the neighboring S (serine) at position 346 in humans and at position 347 in mouse is phosphorylated under wild‐type conditions, and whether this phosphorylation is eventually altered due to the mutation of R to T, which alters typical phosphorylation motifs (Pearson &amp; Kemp, <xref ref-type="ref" rid="emmm201505677-bib-0034">1991</xref>). Using quantitative mass spectrometry analysis and isotopically labeled peptides corresponding to the peptide containing S347, we detected that, although described as a potential activity‐related phosphorylation site (Munton <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0033">2007</xref>), S347 neighboring the SNP site showed only minor phosphorylation (4.73% of total PRG‐1, Fig <xref ref-type="fig" rid="emmm201505677-fig-0001">1</xref>G). In addition, in PRG‐1<sup>R346T</sup>, we could neither detect any relevant change in phosphorylation of S347 (3.33% of total PRG‐1, Fig <xref ref-type="fig" rid="emmm201505677-fig-0001">1</xref>G), nor any phosphorylation of the T at position 346. To further assess whether S347 phosphorylation is a potential relevant cause for the loss of LPA uptake of PRG‐1<sup>R346T</sup>, we established HEK cell lines with a stable expression of PRG‐1<sup>S347A</sup> and PRG‐1<sup>S347D</sup>, which either mimic the non‐phosphorylated (S347A) status or the phosphorylated status (S347D) of S347. Both cell lines lacked the capacity to significantly internalize TF‐LPA above baseline levels (Fig <xref ref-type="fig" rid="emmm201505677-fig-0001">1</xref>H), strongly arguing against an important role for phosphorylation explaining the loss of function of PRG‐1<sup>R346T</sup> in TF‐LPA internalization, however, pointing to the need of <italic>S</italic>347 at this position. Another intracellular posttranslational modification, critically important for brain function is <italic>O</italic>‐GlcNAC glycosylation (Rexach <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0037">2008</xref>), which occurs at S and T residues and has a complex interplay with phosphorylation (Tarrant <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0042">2012</xref>). Using immunoprecipitation studies and specific antibodies, we analyzed <italic>O</italic>‐GlcNAC glycosylation in wtPRG‐1 in comparison with PRG‐1<sup>R346T</sup> and detected significantly reduced glycosylation levels in PRG‐1<sup>R346T</sup>‐expressing cells (Fig <xref ref-type="fig" rid="emmm201505677-fig-0001">1</xref>I and J), indicating an interference of the R346T mutation with its neighboring S347 O‐glycosylation site. Since neither A nor D is a target for <italic>O</italic>‐GlcNAC glycosylation and the cell lines expressing PRG‐1<sup>S347A</sup> and PRG‐1<sup>S347D</sup> lacked the capacity of internalizing TF‐LPA (Fig <xref ref-type="fig" rid="emmm201505677-fig-0001">1</xref>H), these data point to the necessity of an O‐glycosylation at S for proper PRG‐1 function, which is altered in PRG‐1<sup>R346T</sup>.</p>
<p>In sum, these data on posttranslational modifications provide evidence for the fact that not changes in phosphorylation, but proper O‐glycosylation of S at position 346 in humans interfered by the R345T SNP is crucial for PRG‐1 function.</p>
</sec>
<sec id="emmm201505677-sec-0005">
<title>PRG‐1<sup>R346T</sup> is a loss‐of‐function mutation at the synapse</title>
<p>To analyze potential functional consequences of the human SNP in neurons, we moved on in assessing PRG‐1<sup>R346T</sup> function at the synapse and performed whole‐cell patch‐clamp recordings from layer IV spiny stellate neurons in the S1BF of PRG‐1<sup>−/−</sup> animals that re‐expressed PRG‐1<sup>R346T</sup> delivered by <italic>in utero</italic> electroporation (Fig <xref ref-type="fig" rid="emmm201505677-fig-0002">2</xref>A). This re‐expression resulted in proper localization of PRG‐1<sup>R346T</sup> protein at the spine head membrane, excluding an impact of this mutation in protein targeting (Fig <xref ref-type="fig" rid="emmm201505677-fig-0002">2</xref>B). While re‐expression of wtPRG‐1 in PRG‐1‐deficient neurons was reported to rescue the frequency of miniature excitatory postsynaptic currents (mEPSC) to wild‐type levels in hippocampal CA1 pyramidal cells (Trimbuch <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0044">2009</xref>), PRG‐1<sup>R346T</sup>, albeit present at the proper dendritic localization, failed to achieve this functional rescue. This is consistent with a loss of function of PRG‐1<sup>R346T</sup>, presumably due to its inability to support LPA internalization (Fig <xref ref-type="fig" rid="emmm201505677-fig-0002">2</xref>A and C).</p>
<fig fig-type="Figure" id="emmm201505677-fig-0002" orientation="portrait" position="float" xml:lang="en">
<label>Figure 2</label>
<caption>
<title>
<styled-content style="fixed-case">PRG</styled-content>‐1<sup>R346T</sup> fails to rescue <styled-content style="fixed-case">PRG</styled-content>‐1<sup>−/−</sup> phenotype and to induce significant <styled-content style="fixed-case">TF</styled-content>‐<styled-content style="fixed-case">LPA</styled-content> uptake</title>
<p>
<list id="emmm201505677-list-0003" list-type="simple"><list-item><label>A, B</label><p>
<italic>In utero</italic> electroporation (<styled-content style="fixed-case">IUE</styled-content>) of <styled-content style="fixed-case">PRG</styled-content>‐1<sup>R346T</sup> lead to membrane expression of this construct.</p></list-item><list-item><label>C, D</label><p>
<italic>In vitro</italic> whole‐cell patch‐clamp recordings from <styled-content style="fixed-case">PRG</styled-content>‐1<sup>−/−</sup> layer <styled-content style="fixed-case">IV</styled-content> spiny stellate neurons (S1BF) and of spiny stellate neurons reconstituted with <styled-content style="fixed-case">PRG</styled-content>‐1<sup>R346T</sup> by <styled-content style="fixed-case">IUE</styled-content>. Original traces are shown in (A) (<italic>n </italic>=<italic> </italic>11 <styled-content style="fixed-case">PRG</styled-content>‐1<sup>−/−</sup> neurons and 11 <styled-content style="fixed-case">PRG</styled-content>‐1<sup>R346T</sup>‐reconstituted neurons from 4 mice; <italic>t</italic>‐test).</p></list-item><list-item><label>E</label><p>Bright field image and regions of interest (<styled-content style="fixed-case">ROI</styled-content>s, yellow) of primary neuronal cultures containing <styled-content style="fixed-case">PRG</styled-content>‐1<sup>−/−</sup> neurons.</p></list-item><list-item><label>F</label><p>Detection of transfected neurons via a co‐transfected <styled-content style="fixed-case">IRES</styled-content>‐<styled-content style="fixed-case">GFP</styled-content> cassette by fluorescent illumination. Scale bar: 50 μm.</p></list-item><list-item><label>G</label><p>Baseline fluorescence (calculated as Δf/f) of transfected and non‐transfected neurons prior to <styled-content style="fixed-case">TF</styled-content>‐<styled-content style="fixed-case">LPA</styled-content> stimulation.</p></list-item><list-item><label>H</label><p>
<styled-content style="fixed-case">PRG</styled-content>‐1<sup>wt</sup>‐transfected neurons displayed a clear increase in fluorescence intensity after <styled-content style="fixed-case">TF</styled-content>‐<styled-content style="fixed-case">LPA</styled-content> application (left), while <styled-content style="fixed-case">PRG</styled-content>‐1<sup>R346T</sup>‐transfected neurons were not different from non‐transfected <styled-content style="fixed-case">PRG</styled-content>‐1<sup>−/−</sup> neurons (right).</p></list-item><list-item><label>I</label><p>Fluorescence intensity analysis of the <styled-content style="fixed-case">ROI</styled-content>s revealed significant <styled-content style="fixed-case">TF</styled-content>‐<styled-content style="fixed-case">LPA</styled-content> uptake in <styled-content style="fixed-case">PRG</styled-content>‐1<sup>wt</sup>‐transfected neurons but not in <styled-content style="fixed-case">PRG</styled-content>‐1<sup>R346T</sup>‐transfected neurons (<italic>n </italic>=<italic> </italic>25 neurons per condition; repeated‐measures <styled-content style="fixed-case">ANOVA</styled-content> with Bonferroni <italic>post hoc</italic> correction, ***<italic>P</italic> &lt; 0.0001).</p></list-item><list-item><label>J</label><p>Expression of <styled-content style="fixed-case">GFP</styled-content> or of <styled-content style="fixed-case">PRG</styled-content>‐1<sup>R346T</sup> in wild‐type neurons did not alter <styled-content style="fixed-case">TF</styled-content>‐<styled-content style="fixed-case">LPA</styled-content> uptake when compared to non‐transfected neurons (<italic>n </italic>=<italic> </italic>57 wild‐type, 10 <styled-content style="fixed-case">GFP</styled-content>‐transfected and 10 <styled-content style="fixed-case">PRG</styled-content>‐1<sup>R346T</sup>‐transfected neurons; Kruskal–Wallis test with Dunn's multiple comparison test).</p></list-item><list-item><label>K</label><p>Bright field image and fluorescence image overview showing <styled-content style="fixed-case">TF</styled-content>‐<styled-content style="fixed-case">LPA</styled-content> in neurons with <styled-content style="fixed-case">ROI</styled-content>s (yellow) of a primary neuronal culture.</p></list-item><list-item><label>L</label><p>Fluorescence analysis revealed a significantly lower <styled-content style="fixed-case">TF</styled-content>‐<styled-content style="fixed-case">LPA</styled-content> uptake in <styled-content style="fixed-case">PRG</styled-content>‐1<sup>+/−</sup> neurons when compared to wild‐type neurons (<italic>n </italic>=<italic> </italic>15 neurons per group; unpaired <italic>t</italic>‐test, ***<italic>P</italic> &lt; 0.0001).</p></list-item></list>Data information: Bar diagrams represent mean ± SEM.</p>
</caption>
<graphic id="nlm-graphic-7" xlink:href="EMMM-8-25-g004"></graphic>
</fig>
<p>To directly assess the functional consequences of PRG‐1<sup>R346T</sup> in neurons in terms of their capacity to internalize LPA (Trimbuch <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0044">2009</xref>), we used primary cortical neurons obtained from PRG‐1<sup>−/−</sup> animals either transfected with a <italic>prg‐1</italic>
<sup>wt</sup> or with a <italic>prg‐1</italic>
<sup>R346T</sup> expressing construct (Fig <xref ref-type="fig" rid="emmm201505677-fig-0002">2</xref>E and F) and measured internalization of LPA which was tagged by a fluorescence label (TopFluor, TF‐LPA) in a live imaging mode. TF‐LPA internalization capacity of either PRG‐1<sup>wt</sup> or PRG‐1<sup>R346T</sup> was compared to PRG‐1‐deficient neurons in the same experiment (see also Fig <xref ref-type="fig" rid="emmm201505677-fig-0001">1</xref>G for baseline levels). To exclude bias by the transfection procedure, we assessed the TF‐LPA uptake capacity of GFP‐transfected PRG‐1<sup>−/−</sup> neurons finding no difference to the non‐transfected neurons (Fig <xref ref-type="fig" rid="emmm201505677-fig-0001ev">EV1</xref>). While expression of PRG‐1<sup>wt</sup> in neurons induced a significant increase in TF‐LPA internalization, PRG‐1<sup>R346T</sup> expression failed to do so (Fig <xref ref-type="fig" rid="emmm201505677-fig-0002">2</xref>H and I). To rule out a dominant‐negative effect of PRG‐1<sup>R346T</sup>, we used the same approach and transfected cortical neurons obtained from wild‐type mice either with a <italic>prg‐1</italic>
<sup>R346T</sup> or a control GFP construct and found no alteration on TF‐LPA‐internalization in the transfected neurons (Fig <xref ref-type="fig" rid="emmm201505677-fig-0002">2</xref>J). These studies confirmed that PRG‐1<sup>R346T</sup> was a loss‐of‐function mutation in a neuronal context. Finally, since the reported human SNP was only detected in monoallelic carriers, we analyzed the impact of a monoallelic functional loss in cortical neurons obtained from PRG‐1<sup>+/−</sup> animals and found that already monoallelic PRG‐1 loss was sufficient to significantly decrease TF‐LPA‐internalization when compared to wild‐type neurons (Fig <xref ref-type="fig" rid="emmm201505677-fig-0002">2</xref>K and L).</p>
<fig fig-type="Figure" id="emmm201505677-fig-0001ev" orientation="portrait" position="float" specific-use="collapsible" xml:lang="en">
<label>Figure EV1</label>
<caption>
<title>
<styled-content style="fixed-case">GFP</styled-content> expression in <styled-content style="fixed-case">PRG</styled-content>‐1<sup>−/−</sup> neurons does not influence <styled-content style="fixed-case">TF</styled-content>‐<styled-content style="fixed-case">LPA</styled-content> uptake</title>
<p>Quantitative assessment of non‐transfected <styled-content style="fixed-case">PRG</styled-content>‐1<sup>−/−</sup> and <styled-content style="fixed-case">GFP</styled-content>‐transfected <styled-content style="fixed-case">PRG</styled-content>‐1<sup>−/−</sup> neurons revealed no significant difference in <styled-content style="fixed-case">TF</styled-content>‐<styled-content style="fixed-case">LPA</styled-content> uptake (<italic>n </italic>=<italic> </italic>110 non‐transfected <styled-content style="fixed-case">PRG</styled-content>‐1<sup>−/−</sup> and 34 <styled-content style="fixed-case">GFP</styled-content>‐transfected <styled-content style="fixed-case">PRG</styled-content>‐1<sup>−/−</sup> neurons, unpaired <italic>t</italic>‐test).<named-content content-type="attribution">Data information: Bar diagrams represent mean ± SD.</named-content>
</p>
</caption>
<graphic id="nlm-graphic-9" xlink:href="EMMM-8-25-g003"></graphic>
</fig>
</sec>
<sec id="emmm201505677-sec-0006">
<title>Altered phospholipid modulation due to monoallelic loss of synaptic PRG‐1 affects cortical E/I balance</title>
<p>In order to characterize the role of PRG‐1 in cortical networks, we assessed expression of PRG‐1 in the cerebral cortex and found strong expression in layer IV of the mouse somatosensory barrel field cortex (S1BF; Fig <xref ref-type="fig" rid="emmm201505677-fig-0003">3</xref>A) which was restricted to glutamatergic neurons (Fig <xref ref-type="fig" rid="emmm201505677-fig-0002ev">EV2</xref>). Analysis of subcellular localization revealed that PRG‐1 was expressed at dendritic spines (Fig <xref ref-type="fig" rid="emmm201505677-fig-0003">3</xref>B and C). Since heterozygous deletion of PRG‐1, leaving only one functional <italic>prg‐1</italic> allele, results in a linear reduction of protein expression of approximately 50% (Trimbuch <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0044">2009</xref>), and heterozygous PRG‐1‐deficiency significantly reduced the functional capacity of PRG‐1<sup>+/−</sup> neurons to internalize TF‐LPA in a similar range (Fig <xref ref-type="fig" rid="emmm201505677-fig-0002">2</xref>K and L), PRG‐1<sup>+/−</sup> animals are to be assumed as an animal correlate of human monoallelic PRG‐1<sup>R345T</sup> carriers who only have one functional <italic>prg‐1</italic> allele not affected by the mutation. To understand implications of such a reduced synaptic PRG‐1 function in intracortical information processing, we performed multichannel extracellular recordings in the S1BF cortex of wt and PRG‐1<sup>+/−</sup> mice <italic>in vivo</italic> (Fig <xref ref-type="fig" rid="emmm201505677-fig-0003">3</xref>D). Spontaneous activity analysis in PRG‐1<sup>+/−</sup> mice showed a significant prolongation of multiunit activity (MUA) burst duration when compared to wt mice (Fig <xref ref-type="fig" rid="emmm201505677-fig-0003">3</xref>E and F). This finding points to a change in the cellular E/I balance toward excitation within cortical microcircuitries which has been related to severe behavioral deficits (Yizhar <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0051">2011</xref>).</p>
<fig fig-type="Figure" id="emmm201505677-fig-0003" orientation="portrait" position="float" xml:lang="en">
<label>Figure 3</label>
<caption>
<title>
<styled-content style="fixed-case">PRG</styled-content>‐1 expression in the somatosensory barrel field cortex (S1<styled-content style="fixed-case">BF</styled-content>) and <italic>in vivo</italic> electrophysiological assessment</title>
<p>
<list id="emmm201505677-list-0004" list-type="simple"><list-item><label>A</label><p>
<styled-content style="fixed-case">PRG</styled-content>‐1 is strongly expressed in layer <styled-content style="fixed-case">IV</styled-content> neurons of the S1<styled-content style="fixed-case">BF</styled-content> as shown by the β‐Gal reporter. Scale bar: 100 μm.</p></list-item><list-item><label>B, C</label><p>
<styled-content style="fixed-case">PRG</styled-content>‐1 is localized on dendrites (B) and on <styled-content style="fixed-case">MAP</styled-content>‐2‐positive spines (C). Scale bar: 5 μm.</p></list-item><list-item><label>D–F</label><p>Cortical network assessment in <styled-content style="fixed-case">PRG</styled-content>‐1<sup>+/−</sup> mice as revealed by spontaneous <styled-content style="fixed-case">MUA</styled-content> activity (spikes: lines; bursts: bars) analyzed in wt (11,379 bursts; five mice) and <styled-content style="fixed-case">PRG</styled-content>‐1<sup>+/−</sup> (17,919 bursts; eight mice; unpaired <italic>t</italic>‐test, ***<italic>P</italic> &lt; 0.0001).</p></list-item><list-item><label>G</label><p>
<styled-content style="fixed-case">MUA</styled-content> burst numbers in <styled-content style="fixed-case">PRG</styled-content>‐1<sup>+/−</sup> mice before and after application of the <styled-content style="fixed-case">ATX</styled-content> inhibitor <styled-content style="fixed-case">HA</styled-content>‐130 (<italic>n </italic>=<italic> </italic>9, paired <italic>t</italic>‐test, **<italic>P </italic>=<italic> </italic>0.0053).</p></list-item></list>Data information: Bar diagrams represent mean ± SEM.</p>
</caption>
<graphic id="nlm-graphic-11" xlink:href="EMMM-8-25-g006"></graphic>
</fig>
<fig fig-type="Figure" id="emmm201505677-fig-0002ev" orientation="portrait" position="float" specific-use="collapsible" xml:lang="en">
<label>Figure EV2</label>
<caption>
<title>
<styled-content style="fixed-case">PRG</styled-content>‐1 is not expressed in <styled-content style="fixed-case">GABA</styled-content>ergic neurons in the somatosensory cortex</title>
<p>
<list id="emmm201505677-list-0008" list-type="simple"><list-item><label>A–C</label><p>
<styled-content style="fixed-case">PRG</styled-content>‐1 expression was not detected in inhibitory <styled-content style="fixed-case">GAD</styled-content>67 (A)‐, parvalbumin (<styled-content style="fixed-case">PV</styled-content>, B)‐, or calretinin (<styled-content style="fixed-case">CR</styled-content>, C)‐positive interneurons of the mouse somatosensory barrel field cortex (S1<styled-content style="fixed-case">BF</styled-content>). Scale bar: 10 μm.</p></list-item></list>
</p>
</caption>
<graphic id="nlm-graphic-13" xlink:href="EMMM-8-25-g005"></graphic>
</fig>
</sec>
<sec id="emmm201505677-sec-0007">
<title>Inhibition of LPA synthesis reverts altered cortical information processing in monoallelic PRG‐1‐deficient mice</title>
<p>To test for involvement of phospholipids at the cortical network level, we analyzed the effect of inhibiting the LPA‐synthesizing molecule autotaxin (ATX) which acts upstream of the LPA‐LPA<sub>2</sub>/PRG‐1 axis (Moolenaar &amp; Perrakis, <xref ref-type="ref" rid="emmm201505677-bib-0031">2011</xref>). HA‐130, a recently described specific inhibitor of ATX (Albers <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0001">2010</xref>), significantly decreased spontaneous postsynaptic currents (sPSC), which are the sum of the overall excitatory and inhibitory input reflecting the total E/I balance (Fig <xref ref-type="fig" rid="emmm201505677-fig-0003ev">EV3</xref>). In line with these findings <italic>ex vivo</italic>, concentrations as low as 1 μM, HA 130, applied into the cortex of living PRG‐1<sup>+/−</sup> mice, significantly decreased the number of multiunit activity (MUA) bursts (Fig <xref ref-type="fig" rid="emmm201505677-fig-0003">3</xref>G).</p>
<fig fig-type="Figure" id="emmm201505677-fig-0003ev" orientation="portrait" position="float" specific-use="collapsible" xml:lang="en">
<label>Figure EV3</label>
<caption>
<title>
<styled-content style="fixed-case">ATX</styled-content> inhibition decreases neuronal excitation in single cells</title>
<p>
<styled-content style="fixed-case">ATX</styled-content> inhibition in <styled-content style="fixed-case">PRG</styled-content>‐1<sup>+/−</sup> mice, which display a neuronal hyperexcitability, revealed a significant decrease of spontaneous postsynaptic currents (<styled-content style="fixed-case">sPSC</styled-content>) at increasing concentrations of the <styled-content style="fixed-case">ATX</styled-content> blocker <styled-content style="fixed-case">HA</styled-content>130. <styled-content style="fixed-case">sPSC</styled-content>s are the sum of the overall excitatory and inhibitory input at the single neuron level and reflect the excitation/inhibition (E/I) balance (<italic>n </italic>=<italic> </italic>7, repeated‐measures <styled-content style="fixed-case">ANOVA</styled-content> (<italic>P </italic>=<italic> </italic>0.0002) with Bonferroni's multiple comparison test); **<italic>P </italic>&lt;<italic> </italic>0.01, ***<italic>P </italic>&lt;<italic> </italic>0.001). Bar diagrams represent mean ± SEM.</p>
</caption>
<graphic id="nlm-graphic-15" xlink:href="EMMM-8-25-g007"></graphic>
</fig>
<p>In addition to analysis of spontaneous cortical network activity, we assessed pre‐attentive cortical information processing and measured sensory gating in a double‐pulse whisker stimulation model (Fig <xref ref-type="fig" rid="emmm201505677-fig-0004">4</xref>A). Local field potentials (recorded in the whisker‐specific cortical barrel) in response to repetitive single whisker stimulation elicited larger amplitudes to second stimulus in PRG‐1<sup>+/−</sup> when compared to wt (S1; S2; ISI = 500 ms; Fig <xref ref-type="fig" rid="emmm201505677-fig-0004">4</xref>B). Larger S2 amplitudes altered S1–S2 values and resulted in a statistically significant increase of the S2/S1 ratio (Fig <xref ref-type="fig" rid="emmm201505677-fig-0004">4</xref>C and D). These findings indicate that already loss of one functional allele of <italic>prg‐1</italic> as present in mutPRG‐1 carriers, and thus a reduction of about 50% of functional PRG‐1 at the synapse, causes an apparent E/I imbalance in cortical networks and an altered sensory gating. To prove whether phospholipid modulation is able to directly affect cortical information processing, we applied HA‐130 in the double‐pulse whisker stimulation model (Fig <xref ref-type="fig" rid="emmm201505677-fig-0004">4</xref>E). This inhibition of LPA synthesis significantly restored sensory gating in animals with monoallelic PRG‐1‐deficiency as shown by reduction of S2 values (when compared to S1 values) and a reduced S2/S1 ratio (Fig <xref ref-type="fig" rid="emmm201505677-fig-0004">4</xref>F and G).</p>
<fig fig-type="Figure" id="emmm201505677-fig-0004" orientation="portrait" position="float" xml:lang="en">
<label>Figure 4</label>
<caption>
<title>
<styled-content style="fixed-case">PRG</styled-content>‐1<sup>+/−</sup> mice display an altered sensory gating which is rescued by <styled-content style="fixed-case">ATX</styled-content> inhibition</title>
<p>
<list id="emmm201505677-list-0005" list-type="simple"><list-item><label>A–D</label><p>Paired‐pulse responses (500 ms <styled-content style="fixed-case">ISI</styled-content>) to single whisker mechanical stimulation (trace show average of 30 responses) (A) and analysis of peak amplitudes (B), S1‐S2 difference (C), and S2/S1 ratio (D) (Wilcoxon matched‐pair signed rank test for wtS1 vs. wtS2, *<italic>P</italic> = 0.0137 and unpaired <italic>t</italic>‐test for wtS2 vs. hetS2. *<italic>P</italic> = 0.0118 for B; Mann‐Whitney <italic>U</italic>‐test was used for C and D, *<italic>P</italic> = 0.0446; <italic>n </italic>=<italic> </italic>10 <styled-content style="fixed-case">WT</styled-content> animals and 6 <styled-content style="fixed-case">PRG</styled-content>‐1 het animals.)</p></list-item><list-item><label>E</label><p>Paired‐pulse responses before and after application of the <styled-content style="fixed-case">ATX</styled-content> inhibitor <styled-content style="fixed-case">HA</styled-content>‐130.</p></list-item><list-item><label>F, G</label><p>Peak amplitudes and S2/S1‐ratio before and after <styled-content style="fixed-case">ATX</styled-content> inhibition by <styled-content style="fixed-case">HA</styled-content>‐130 (<italic>n </italic>=<italic> </italic>6 animals). Data comparing paired‐pulse responses before and after application of <styled-content style="fixed-case">HA</styled-content>‐130 were assessed by a one‐tailed paired <italic>t</italic>‐test (**<italic>P </italic>=<italic> </italic>0.0093, *<italic>P </italic>=<italic> </italic>0.0134).</p></list-item></list>Data information: Box plots represent the 25<sup>th</sup> and 75<sup>th</sup> percentile. The middle line shows the 50<sup>th</sup> percentile (median). Whiskers indicate the 10<sup>th</sup> and 90<sup>th</sup> percentiles.</p>
</caption>
<graphic id="nlm-graphic-17" xlink:href="EMMM-8-25-g008"></graphic>
</fig>
</sec>
<sec id="emmm201505677-sec-0008">
<title>Pharmacological intervention into monoallelic PRG‐1 deficiency reverts behavioral deficits characteristic for mental disorders</title>
<p>To answer the question whether observed alterations in excitatory synaptic function and cortical network activity result in a behavioral phenotype, we assessed monoallelic PRG‐1‐deficient animals (PRG‐1<sup>+/−</sup>). Using a three chambered box paradigm (Radyushkin <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0036">2009</xref>), we found a significantly reduced social interaction index in PRG‐1<sup>+/−</sup> mice (Figs <xref ref-type="fig" rid="emmm201505677-fig-0005">5</xref>A and <xref ref-type="fig" rid="emmm201505677-fig-0004ev">EV4</xref>A). We further assessed PRG‐1<sup>+/−</sup> mice under normal conditions and after application of environmental stress, known to be a risk factor for mental disorders (van Winkel <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0049">2008</xref>). While PRG‐1<sup>+/−</sup> mice displayed no differences under normal conditions in tail suspension tests, following acute stress, PRG‐1<sup>+/−</sup> mice showed a significantly higher immobility (Fig <xref ref-type="fig" rid="emmm201505677-fig-0005">5</xref>B), indicative of alterations of resilient behaviors resembling aspects of stress‐related mental disorders (Cryan <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0011">2005</xref>; Shen <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0039">2008</xref>; Inta <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0022">2010</xref>).</p>
<fig fig-type="Figure" id="emmm201505677-fig-0005" orientation="portrait" position="float" xml:lang="en">
<label>Figure 5</label>
<caption>
<title>
<styled-content style="fixed-case">PRG</styled-content>‐1<sup>+/−</sup> mice display an endophenotype typical for psychiatric disorders which was rescued by <styled-content style="fixed-case">ATX</styled-content> inhibition</title>
<p>
<list id="emmm201505677-list-0006" list-type="alpha-upper"><list-item><p>The social interaction index was significantly reduced in <styled-content style="fixed-case">PRG</styled-content>‐1<sup>+/−</sup> (het) mice (<italic>n </italic>=<italic> </italic>12 wild‐type and 14 het mice; unpaired <italic>t</italic>‐test, *<italic>P </italic>=<italic> </italic>0.035).</p></list-item><list-item><p>Tail suspension test under normal conditions and after exposure to acute restrain stress (<italic>n </italic>=<italic> </italic>14 <styled-content style="fixed-case">PRG</styled-content>‐1 het and 12 wt animals; unpaired <italic>t</italic>‐test, *<italic>P </italic>=<italic> </italic>0.0214).</p></list-item><list-item><p>
<styled-content style="fixed-case">PRG</styled-content>‐1<sup>+/−</sup> mice displayed a robust deficit in <styled-content style="fixed-case">PPI</styled-content> at all pre‐pulse stimuli (*<italic>P </italic>=<italic> </italic>0.0178). <styled-content style="fixed-case">ATX</styled-content> inhibition via <styled-content style="fixed-case">PF</styled-content>8380 treatment significantly rescued the <styled-content style="fixed-case">PPI</styled-content> deficit in <styled-content style="fixed-case">PRG</styled-content>‐1<sup>+/−</sup> mice to a level which was not different to the <styled-content style="fixed-case">PPI</styled-content> measured in wt mice (<italic>n </italic>=<italic> </italic>19 wt animals, 12 <styled-content style="fixed-case">PRG</styled-content>‐1 het animals, and 10 <styled-content style="fixed-case">PRG</styled-content>‐1 het animals + <styled-content style="fixed-case">PF</styled-content>8380; two‐way <styled-content style="fixed-case">ANOVA</styled-content> with Bonferroni <italic>post hoc</italic>, **<italic>P </italic>=<italic> </italic>0.0068).</p></list-item></list>Data information: Bar diagrams represent mean ± SEM.</p>
</caption>
<graphic id="nlm-graphic-19" xlink:href="EMMM-8-25-g010"></graphic>
</fig>
<fig fig-type="Figure" id="emmm201505677-fig-0004ev" orientation="portrait" position="float" specific-use="collapsible" xml:lang="en">
<label>Figure EV4</label>
<caption>
<title>Decreased <styled-content style="fixed-case">LPA</styled-content> levels in the <styled-content style="fixed-case">CSF</styled-content> after <styled-content style="fixed-case">ATX</styled-content> inhibition</title>
<p>
<list id="emmm201505677-list-0009" list-type="alpha-upper"><list-item><p>To exclude bias in the social alteration by lower motility, total distance traveled by the mice of the different genotypes was analyzed and was not different between genotypes (Mann–Whitney <italic>U</italic>‐test; <italic>n </italic>=<italic> </italic>13 wt and 15 <styled-content style="fixed-case">PRG</styled-content>‐1 het mice).</p></list-item><list-item><p>
<styled-content style="fixed-case">LPA</styled-content> levels in the cerebrospinal fluid measured by mass spectrometry 3 h after i.p. application of vehicle (<styled-content style="fixed-case">DMSO</styled-content>) or of the <italic>in vivo </italic>
<styled-content style="fixed-case">ATX</styled-content> inhibitor <styled-content style="fixed-case">PF</styled-content>8380 in <styled-content style="fixed-case">PRG</styled-content>‐1<sup>+/−</sup> mice revealed a significant decrease of the main <styled-content style="fixed-case">LPA</styled-content> subtypes (<italic>n </italic>=<italic> </italic>6 samples pooled from 2 animals per sample and <italic>n </italic>=<italic> </italic>5 for <styled-content style="fixed-case">LPA</styled-content>18:2 Het + <styled-content style="fixed-case">PF</styled-content>8380; unpaired, one‐tailed <italic>t</italic>‐test, for <styled-content style="fixed-case">LPA</styled-content>16:0 *<italic>P </italic>=<italic> </italic>0.0219, <styled-content style="fixed-case">LPA</styled-content> 18:1 *<italic>P </italic>=<italic> </italic>0.0398; due to sophisticated <styled-content style="fixed-case">CSF</styled-content> extraction, which may be biased by blood contamination, values exceeding mean + 2 × <styled-content style="fixed-case">SD</styled-content> were excluded).</p></list-item></list>
</p>
<p>
<named-content content-type="attribution">Data information: Bar diagrams represent mean ± SEM.</named-content>
</p>
</caption>
<graphic id="nlm-graphic-21" xlink:href="EMMM-8-25-g009"></graphic>
</fig>
<p>Since reduced social interaction and altered behavior in tail suspension test reflect symptoms of stress‐related mental disorders and alterations in resilient behaviors, we assessed pre‐pulse inhibition (PPI) in these animals. PPI is highly conserved among vertebrates, is indicative for altered mental function, and is one of few paradigms in which humans and rodents are tested in similar fashions (Davis, <xref ref-type="ref" rid="emmm201505677-bib-0012">1984</xref>). Based on this, we studied PPI of the startle response in PRG‐1<sup>+/−</sup> (het) and wild‐type (wt) mice finding that PRG‐1<sup>+/−</sup> animals showed a significant decrease of PPI in comparison with wt littermates (Fig <xref ref-type="fig" rid="emmm201505677-fig-0005">5</xref>C). To test whether pharmacological treatment is able to revert these behavioral abnormalities indicative for mental disorders, we tested an <italic>in vivo</italic> inhibitor of the LPA‐synthesizing enzyme autotaxin (PF8380) which has a nanomolar potency and can be applied orally or by injection to the periphery (Gierse <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0015">2010</xref>). Intraperitoneal injection of PF8380 significantly diminished LPA levels in the cerebrospinal fluid (Fig <xref ref-type="fig" rid="emmm201505677-fig-0004ev">EV4</xref>B) and effectively restored the observed PPI deficit in freely moving PRG‐1<sup>+/−</sup> mice to wild‐type levels (Fig <xref ref-type="fig" rid="emmm201505677-fig-0005">5</xref>C).</p>
</sec>
<sec id="emmm201505677-sec-0009">
<title>PRG‐1<sup>R345T</sup>: a human SNP associated with an endophenotype for mental disorders</title>
<p>Analysis of PRG‐1 expression in the human cortex revealed strong neuronal PRG‐1 signals and a clear expression in layer IV neurons (Fig <xref ref-type="fig" rid="emmm201505677-fig-0006">6</xref>A). Using specific markers like GAD67, parvalbumin, and calretinin, we found specific PRG‐1 expression in glutamatergic neurons but not in interneurons (Fig <xref ref-type="fig" rid="emmm201505677-fig-0005ev">EV5</xref>A–C). Further subcellular analysis revealed dendritic co‐localization of PRG‐1 with the postsynaptic density marker PSD95 (Fig <xref ref-type="fig" rid="emmm201505677-fig-0006">6</xref>B) confirming specific postsynaptic PRG‐1 expression in glutamatergic synapses of excitatory neurons as described in the rodent brain (Trimbuch <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0044">2009</xref>).</p>
<fig fig-type="Figure" id="emmm201505677-fig-0006" orientation="portrait" position="float" xml:lang="en">
<label>Figure 6</label>
<caption>
<title>
<styled-content style="fixed-case">PRG</styled-content>‐1 R345T: a loss‐of‐function human mutation induces an endophenotype for mental disorders</title>
<p>
<list id="emmm201505677-list-0007" list-type="alpha-upper"><list-item><p>
<styled-content style="fixed-case">PRG</styled-content>‐1 is expressed in NeuN‐positive neurons of the somatosensory human cortex. Remark the <styled-content style="fixed-case">PRG</styled-content>‐1 expression delineating dendritic profiles of NeuN‐positive neurons. Insert depicts dendritic <styled-content style="fixed-case">PRG</styled-content>‐1 expression in a layer <styled-content style="fixed-case">IV</styled-content> spiny stellate neuron at higher magnification. Scale bar: 100 μm.</p></list-item><list-item><p>
<styled-content style="fixed-case">PRG</styled-content>‐1 and <styled-content style="fixed-case">PSD</styled-content>‐95 punctae delineate dendritic profiles of a pyramidal neuron. Higher magnification (insert) exemplarily shows <styled-content style="fixed-case">PRG</styled-content>‐1/<styled-content style="fixed-case">PSD</styled-content>95 co‐localization (arrow heads).</p></list-item><list-item><p>Stratified analysis of <italic>prg‐1</italic> genotype on P50 event‐related potential in mut<styled-content style="fixed-case">PRG</styled-content>‐1 carriers.</p></list-item></list>
</p>
</caption>
<graphic id="nlm-graphic-23" xlink:href="EMMM-8-25-g012"></graphic>
</fig>
<fig fig-type="Figure" id="emmm201505677-fig-0005ev" orientation="portrait" position="float" specific-use="collapsible" xml:lang="en">
<label>Figure EV5</label>
<caption>
<title>
<styled-content style="fixed-case">PRG</styled-content>‐1 is not expressed in cortical interneurons of the human somatosensory cortex</title>
<p>
<list id="emmm201505677-list-0010" list-type="simple"><list-item><label>A</label><p>Overview of <styled-content style="fixed-case">PRG</styled-content>‐1 and <styled-content style="fixed-case">GAD</styled-content>67 expression shows distinct non‐overlapping localization. Remark the clear non‐overlapping delineation of <styled-content style="fixed-case">PRG</styled-content>‐1‐expressing neurons (green arrows) and <styled-content style="fixed-case">GAD</styled-content>67‐interneurons (red arrows).</p></list-item><list-item><label>B, C</label><p>Higher magnification shows a parvalbumin (<styled-content style="fixed-case">PV</styled-content>)‐ and a calretinin (<styled-content style="fixed-case">CR</styled-content>)‐positive interneuron confirming no expression of <styled-content style="fixed-case">PRG</styled-content>‐1 in these interneurons. Since autofluorescence is a common feature in human tissue and might lead to interpretation bias, we have illustrated the extent of autofluorescence in each depicted neuron by using a 633‐nm laser line which excites only autofluorescent material but not the secondary antibodies labeled with Alexa 488 (against <styled-content style="fixed-case">PRG</styled-content>‐1 antibody) and 568 (against <styled-content style="fixed-case">PV</styled-content> and <styled-content style="fixed-case">CR</styled-content> antibodies) which were excited with a laser line of 488 nm and 568 nm, respectively. Note the <styled-content style="fixed-case">PRG</styled-content>‐1 expression in the nearby located <styled-content style="fixed-case">PV</styled-content>‐negative neuron in (B).</p></list-item></list>
</p>
<p>
<named-content content-type="attribution">Data information: Scale bars: 50 μm (A), 5 μm (B, C).</named-content>
</p>
</caption>
<graphic id="nlm-graphic-25" xlink:href="EMMM-8-25-g011"></graphic>
</fig>
<p>To prove for the relevance of PRG‐1 and its loss‐of‐function SNP in humans, we analyzed a well‐characterized sample of 1,811 healthy adult German subjects (Brinkmeyer <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0005">2011</xref>; Lindenberg <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0028">2011</xref>; Quednow <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0035">2012</xref>) (see <xref ref-type="supplementary-material" rid="emmm201505677-sup-0001">Appendix Table S1</xref> for sociodemographic variables) where we detected the PRG‐1<sup>R345T</sup> (mutPRG‐1) variant at a heterozygous frequency of 0.66% (12 carriers). EEG analysis of PRG‐1<sup>+/mut</sup> carriers revealed alterations of the P50 event‐related cortical potential (ERP) elicited by an auditory double‐stimulus paradigm (stimulus 1 = S1, stimulus 2 = S2), a measure of pre‐attentive stimulus processing/sensory gating and an endophenotype for mental disorders (Turetsky <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0047">2007</xref>; Javitt <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0023">2008</xref>). PRG‐1<sup>+/mut</sup> carriers showed larger P50 amplitudes in response to the second stimulus (S2), a finding pointing to an excitation–inhibition imbalance and deficient “gating out” of redundant information (Chang <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0006">2011</xref>) (Fig <xref ref-type="fig" rid="emmm201505677-fig-0006">6</xref>C). S1 reduction and S2 increase/diminished suppression may both contribute to sensory gating abnormalities in mental disorders but have been considered to reflect distinct/partially overlapping processes with a non‐identical genetic architecture (Javitt <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0023">2008</xref>; Chang <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0006">2011</xref>).</p>
<p>Since PRG‐1 is expressed in human excitatory neurons in the somatosensory cortex (Figs <xref ref-type="fig" rid="emmm201505677-fig-0006">6</xref>A and B and <xref ref-type="fig" rid="emmm201505677-fig-0005ev">EV5</xref>A–C), and PRG‐1‐deficient mice (PRG‐1<sup>−/−</sup>) display hippocampal hyperexcitability (Trimbuch <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0044">2009</xref>), the electrophysiological phenotype of human PRG‐1<sup>+/mut</sup> carriers suggested a functional alteration of mutPRG‐1. This apparently lead to an increased synaptic glutamate release at excitatory neurons thus inducing a shift in the E/I balance toward excitation (Yizhar <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0051">2011</xref>) and an altered function of cortical networks as observed in the pathophysiology of mental disorders (Coyle, <xref ref-type="ref" rid="emmm201505677-bib-0010">2006</xref>; Belforte <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0003">2010</xref>; Javitt <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0024">2011</xref>).</p>
</sec>
</sec>
<sec id="emmm201505677-sec-0010">
<title>Discussion</title>
<p>Bioactive lipid signaling at the synapse has only recently been shown to be involved in the control of glutamatergic transmission. Evidence from studies in hippocampal neurons highlights lysophosphatidic acid (LPA) as an active substance stimulating presynaptic LPA receptors which in turn control glutamate release from the presynaptic terminal (Trimbuch <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0044">2009</xref>). Synaptic LPA appears to be under tight control of the postsynaptic lipid phosphatase‐like molecule PRG‐1 (Brauer <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0004">2003</xref>; McDermott <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0030">2004</xref>), while lack of PRG‐1 and thus insufficient control of synaptic LPA action result in overexcitation and eventually hippocampal epilepsy (Trimbuch <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0044">2009</xref>). We found that a single nucleotide polymorphism (SNP) in the human <italic>prg‐1</italic> gene resulting in a single amino acid exchange (R345T in humans, mutPRG‐1; homolog in mouse: R346T) turned out to be a loss‐of‐function mutation of PRG‐1. This SNP with a monoallelic frequency of ~0.6% affects ~3.5 million European and ~1.5 million US citizens and is homologous to the SNP (rs138327459) reported by the NHLBI Exome Sequencing Project (<ext-link ext-link-type="uri" xlink:href="https://esp.gs.washington.edu/drupal/">https://esp.gs.washington.edu/drupal/</ext-link>) in the isoform 2 of PRG‐1 (NP_001159724). Here, we analyzed the underlying molecular cause of this loss‐of‐function SNP and show that loss of function of postsynaptic PRG‐1 at the glutamatergic synapse leads to an endophenotype (reduced sensory gating) described in schizophrenia.</p>
<p>Phosphorylation is an important posttranslational modification of synaptic proteins critically influencing their function (Lu &amp; Roche, <xref ref-type="ref" rid="emmm201505677-bib-0029">2012</xref>). Since studies from different laboratories (Munton <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0033">2007</xref>; Trinidad <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0045">2008</xref>; Huttlin <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0021">2010</xref>; Wisniewski <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0050">2010</xref>; Goswami <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0016">2012</xref>) have identified S347 as phosphorylation site in PRG‐1, which together with the preceding R346 forms a typical phosphorylation motif (Pearson &amp; Kemp, <xref ref-type="ref" rid="emmm201505677-bib-0034">1991</xref>), we have analyzed the phosphorylation status of wild‐type PRG‐1 and PRG‐1<sup>R346T</sup>. Interestingly, applying quantitative studies using isotopically labeled peptides, we neither detected a biologically significant amount of S347 phosphorylation in wild‐type PRG‐1 (wtPRG‐1), nor a significant change in the mouse SNP homolog (PRG‐1<sup>R346T</sup>). This was corroborated by two mutation studies (PRG‐1<sup>S347A</sup> and PRG‐1<sup>S347D</sup>) mimicking the non‐phosphorylated and the constitutive phosphorylated form, which both failed to significantly take up TF‐LPA pointing to the necessity of S at this position (S347). However, assessment of <italic>O</italic>‐GlcNAc glycosylation, another posttranslational modification critical for correct brain function (Cole &amp; Hart, <xref ref-type="ref" rid="emmm201505677-bib-0008">2001</xref>; Tallent <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0041">2009</xref>) occurring at S and T residues and found in a reciprocal interplay with phosphorylation (Cheng &amp; Hart, <xref ref-type="ref" rid="emmm201505677-bib-0007">2001</xref>), revealed significantly reduced glycosylation levels in PRG‐1<sup>R346T</sup> when compared to wtPRG‐1. Interestingly, <italic>O</italic>‐GlcNAC glycosylation typically occurs in intrinsically disordered protein regions (Trinidad <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0046">2012</xref>) as present in the intracellular C‐term of PRG‐1 containing S347 and, although consensus motifs of the responsible enzyme GlcNAc‐β‐Ser/Thr (OGT) have not been set (Moremen <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0032">2012</xref>), arginine (R) located next to <italic>O</italic>‐GlcNAC glycosylation sites was described for many proteins (for overview see Lazarus <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0026">2011</xref>). Altogether, our data point to glycosylation as a critical mechanism for PRG‐1 function, which was significantly reduced by the PRG‐1<sup>R346T</sup> SNP.</p>
<p>To prove that mutPRG‐1 is a loss‐of‐function mutation also in a neuronal context, we re‐expressed the mouse homolog of the human SNP (PRG‐1<sup>R346T</sup>) in PRG‐1<sup>−/−</sup> mice and assessed synaptic function using single cell electrophysiology. While it was shown that PRG‐1 reconstitution in the hippocampus restored high mEPSC to normal levels (Trimbuch <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0044">2009</xref>), PRG‐1<sup>R346T</sup> re‐expression, although correctly localized at dendritic spines, failed to do so. In line, functional analyses of PRG‐1<sup>WT</sup>‐ or PRG‐1<sup>R346T</sup>‐reconstituted PRG‐1<sup>−/−</sup> neurons in terms to modulate extracellular LPA showed that PRG‐1<sup>R346T</sup> reconstitution failed to induce significant TF‐LPA uptake which was present in PRG‐1<sup>WT</sup>‐reconstituted neurons. However, since (i) PRG‐1<sup>R346T</sup> reconstitution did not exert a dominant‐negative effect on TF‐LPA uptake when expressed in WT neurons and (ii) neurons with monoallelic PRG‐1 deletion (PRG‐1<sup>+/−</sup>) displayed 50% reduction in TF‐LPA uptake, which corresponds to the halfway reduction of the PRG‐1 protein in PRG‐1<sup>+/−</sup> mice (Trimbuch <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0044">2009</xref>), our data show that heterozygous PRG‐1 mice are a valid animal model to study synaptic alterations present in monoallelic PRG‐1<sup>WT/mut</sup> carriers.</p>
<p>Increased glutamate at the synapse is involved in a broad range of diseases and alterations in cortical excitation/inhibition (E/I) balance have been suggested to contribute to the pathophysiology underlying mental disorders (Yizhar <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0051">2011</xref>). In our present study, we could show that control of glutamatergic transmission by bioactive lipid signaling is an important prerequisite for proper cortical information processing. PRG‐1 is highly expressed in layer IV neurons of the somatosensory cortex and already 50% reduction of functional active PRG‐1 at the glutamatergic synapse caused reduced LPA uptake into postsynaptic neurons, and as a consequence, shifted E/I balance toward a higher excitability of cortical networks leading to pathological cortical information processing as observed in schizophrenia (Coyle, <xref ref-type="ref" rid="emmm201505677-bib-0010">2006</xref>; Belforte <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0003">2010</xref>; Hasan <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0018">2012a</xref>, <xref ref-type="ref" rid="emmm201505677-bib-0020">2012b</xref>; Yizhar <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0051">2011</xref>). This functional impairment leads to decreased social interaction, loss of resilience in tail suspension test after acute stress application, and decreased PPI which are well‐established animal correlates of altered mental function (Shen <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0039">2008</xref>; Inta <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0022">2010</xref>). Using PRG‐1<sup>+/−</sup> mice, which resemble the PRG‐1<sup>WT/mut</sup> situation present in human SNP carriers, we could show for the first time that proper bioactive lipid signaling at the synapse is important for cortical information processing. This is supported by data obtained from EEG analyses in humans showing that P50 event‐related potentials, a measure of sensory processing and gating reflecting E/I balance alterations and impaired cortical network function, were significantly altered in monoallelic mutPRG‐1 human carriers. In sum, our study thus provides a translational line of evidence showing that alterations in E/I balance and pre‐attentive stimulus processing, which are considered biomarkers/endophenotypes of psychiatric disorders (Coyle, <xref ref-type="ref" rid="emmm201505677-bib-0010">2006</xref>; Javitt <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0023">2008</xref>, <xref ref-type="ref" rid="emmm201505677-bib-0024">2011</xref>) and are present in PRG‐1<sup>+/mut</sup> carriers, result from a reduced PRG‐1 action at the synapse, leading to increased LPA levels and loss of proper cortical network function. Our study indicates a role of PRG‐1<sup>R346T</sup> as a potential susceptibility gene for human neuropsychiatric disorders.</p>
<p>Our results provide further support for the notion that cortical excitation/inhibition imbalances contribute to glutamate‐related electrophysiological and behavioral abnormalities in psychiatric disorders (e.g., the glutamate hypothesis of schizophrenia). Moreover, they suggest that proper bioactive lipid signaling is important for normal sensory discrimination and learning, which both depend on synaptic homeostatic plasticity controlling accurate E/I balance as a prerequisite for appropriate resilience against stress‐related mental dysfunction (Kalisch <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0025">2015</xref>). Thus, in addition to the known NMDA receptor hypofunction on inhibitory neurons (reduced feed‐forward inhibition), alteration of glutamatergic activity on excitatory neurons (increased feed‐forward excitation) may contribute to psychiatric diseases (Coyle, <xref ref-type="ref" rid="emmm201505677-bib-0010">2006</xref>; Belforte <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0003">2010</xref>; Javitt <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0024">2011</xref>; Yizhar <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0051">2011</xref>).</p>
<p>Since modulation of the phospholipid signal cascade using LPA synthesis inhibitors acting upstream of PRG‐1 was effective in reverting the decreased sensory gating and the altered behavior in PRG‐1<sup>+/−</sup> mice toward wild‐type levels, our data provide evidence that E/I balance critically depends on accurate regulation of synaptic LPA levels. This synaptic regulatory mechanism seems to depend on a proper posttranslational modification like glycosylation of the synaptic phospholipid modulator PRG‐1 and alterations in this signaling pathway may result in altered cortical information processing.</p>
<p>LPA levels are controlled by its synthesizing enzyme, autotaxin on the one hand (Moolenaar &amp; Perrakis, <xref ref-type="ref" rid="emmm201505677-bib-0031">2011</xref>), and by PRG‐1 from the postsynaptic side on the other (Trimbuch <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0044">2009</xref>). Our previous studies in the hippocampus have shown that affecting this LPA signaling pathway by additional LPA<sub>2</sub> receptor deletion rescues the phenotype observed in animals lacking synaptic control of bioactive lipid signaling due to PRG‐1 deficiency (Trimbuch <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0044">2009</xref>). In the present study, we show that an upstream intervention in the LPA‐LPA<sub>2</sub>/PRG‐1 signaling axis (achieved by ATX inhibition) rescued the E/I balance in the same way (reducing the higher spontaneous glutamate release and restoring sensory (double‐pulse whisker stimulation model) and sensorimotor gating (PPI) in PRG‐1<sup>+/−</sup> mice) as shown in our genetic studies using PRG‐1<sup>−/−</sup>//LPA<sub>2</sub>
<sup>−/−</sup> deficient mice strains.</p>
<p>In sum, pharmacological intervention in the animal model of mutPRG‐1 via upstream manipulation of the above‐described pathway using available ATX inhibitors was successful in rescuing sensorimotor gating (PPI) at electrophysiological and behavioral level, known to resemble aspects of mental disorders (Swerdlow <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0040">1994</xref>; Cryan <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0011">2005</xref>; Radyushkin <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0036">2009</xref>). Clearly, further in‐depth prospective analysis of PRG‐1<sup>+/mut</sup> carriers and case–control studies in patient cohorts with psychiatric diseases is needed to ultimately design novel treatment approaches based on targeted intervention to synaptic lipid signaling. However, our data suggest that interfering with LPA signaling via inhibitors of autotaxin might thus represent a promising strategy to treat the human phenotype of PRG‐1<sup>WT/mut</sup> or other stress‐mediated behavioral alterations and glutamate‐related mental disorders (Harrison &amp; Weinberger, <xref ref-type="ref" rid="emmm201505677-bib-0017">2005</xref>; Coyle, <xref ref-type="ref" rid="emmm201505677-bib-0010">2006</xref>; Belforte <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0003">2010</xref>; Javitt <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0024">2011</xref>; Hasan <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0020">2012b</xref>; Kalisch <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0025">2015</xref>).</p>
</sec>
<sec id="emmm201505677-sec-0011">
<title>Materials and Methods</title>
<sec id="emmm201505677-sec-0012">
<title>Electrophysiological and behavioral studies in mice</title>
<p>All experiments were conducted in mice on a C57BL/6J background in accordance with the national laws for the use of animals in research and with the European Communities Council Directive 86/609/EEC and approved by the local ethical committee (Landesuntersuchungsamt Rheinland‐Pfalz 23.177‐07/G 10‐1‐010 and 23. 177‐07/G 12‐1‐096). Experiments were designed to minimize the number of animals used. PRG‐1<sup>−/−</sup> mice were obtained by genetic modification as described in Trimbuch <italic>et al</italic> (<xref ref-type="ref" rid="emmm201505677-bib-0044">2009</xref>) and backcrossed on a C57Bl/6J background (Jackson) for at least 10 generations. <italic>In utero</italic> electroporation, recordings <italic>in vitro</italic> and <italic>in vivo</italic> were performed following standard protocols and are described in more detail in the <xref ref-type="supplementary-material" rid="emmm201505677-sup-0001">Appendix Supplementary Methods</xref>.</p>
</sec>
<sec id="emmm201505677-sec-0013">
<title>LPA uptake assay</title>
<p>HEK293 cells and HEK293 cell lines expressing wild‐type PRG‐1, PRG‐1<sup>R346T</sup> (corresponding to the human R345T mutation), PRG‐1<sup>S346A</sup>, and PRG‐1<sup>S346D</sup> were incubated with TF‐LPA [Avanti Polar Lipids, USA (Saunders <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0038">2011</xref>)] at 1 μM for 5 min at 37°C. After removing TF‐LPA from the cell surface by washing the cells (3 × 5 min) with 0.001% SDS in DMEM, cells were assessed by flow cytometry (FACSCanto II, Becton Dickinson, USA) and analyzed by the FlowJo software (Tree Star, USA). TF‐LPA uptake was either calculated as changes of internalized TF‐LPA when compared to non‐transfected HEK293 cells or to PRG‐1‐expressing cells. In another set of experiments, cells were incubated with non‐natural lipid C17‐LPA (Avanti Polar Lipids, USA) instead of TF‐LPA. C17‐LPA and its degradation product C17‐MG were subsequently assessed by mass spectrometry. Primary neuronal cultures were prepared and transfected according to standard procedures. TF‐LPA stimulation and optical detection of neuronal TF‐LPA uptake was performed as described in the <xref ref-type="supplementary-material" rid="emmm201505677-sup-0001">Appendix Supplementary Methods</xref>.</p>
</sec>
<sec id="emmm201505677-sec-0014">
<title>Quantitative phosphorylation studies</title>
<p>Isotopically labeled peptides (Heavy Peptide<sup>™</sup> AQUA QuantPro) were purchased from Thermo Fisher Scientific (Waltham, MA). For assessing S347 phosphorylation in wt PRG‐1 and in PRG‐1<sup>R346T</sup> following heavy isotope labeled peptides were used: SLTDLNQDPS[R(13C6;15N4)], DALRSLTDLNQDPS[R(13C6;15N4)], DALR[S(PO3H2)]LTDLNQDPS[R(13C6;15N4)], DALT[S(PO3H2)]LTDLNQDPS[R(13C6;15N4)], and DALTSLTDLNQDPS[R(13C6;15N4)]. Proteolytic digestion and quantitative liquid chromatography–ion mobility separation–mass spectrometry (LC‐IMS‐MS) was performed as described in the <xref ref-type="supplementary-material" rid="emmm201505677-sup-0001">Appendix Supplementary Methods</xref>.</p>
</sec>
<sec id="emmm201505677-sec-0015">
<title>Glycosylation studies using co‐immunoprecipitation and Western blotting</title>
<p>For glycosylation studies, co‐IP was performed using protein G agarose beads and a custom‐made anti‐PRG‐1 antibody (Trimbuch <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0044">2009</xref>) according to standard procedures. Western blotting was performed using a anti‐O‐GlcNAc antibody (1:1,000 dilution; CTD110.6, Cell Signaling, USA). For quantification, membranes were stripped and the total amount of PRG‐1 was assessed using the above‐described anti‐PRG‐1 antibody. For details, see <xref ref-type="supplementary-material" rid="emmm201505677-sup-0001">Appendix Supplementary Methods</xref>.</p>
</sec>
<sec id="emmm201505677-sec-0016">
<title>Immunostaining</title>
<p>Cell labelings were performed using established antibodies and following standard protocols. For details, see <xref ref-type="supplementary-material" rid="emmm201505677-sup-0001">Appendix Supplementary Methods</xref>.</p>
</sec>
<sec id="emmm201505677-sec-0017">
<title>Behavioral analyses</title>
<p>All experiments were conducted in accordance with the national laws for the use of animals in research and with the European Communities Council Directive 86/609/EEC and were approved by the local ethical committee (Landesuntersuchungsamt, Rheinland‐Pfalz, Germany, #23 177‐07/G 12‐1‐096). Social interaction, PPI, and tail suspension test (before and after acute stress) were conducted as described elsewhere. For details, see <xref ref-type="supplementary-material" rid="emmm201505677-sup-0001">Appendix Supplementary Methods</xref>.</p>
</sec>
<sec id="emmm201505677-sec-0018">
<title>Pharmacological intervention</title>
<p>Animals were treated using the <italic>in vivo</italic> potent autotaxin inhibitor PF 8380 (Gierse <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0015">2010</xref>). Animals received a single i.p. injection 3 h prior to PPI. PF8380 concentration in the cerebrospinal fluid (CSF) was measured by mass spectrometry 3 h after injection, yielding a concentration up to 0.42 pmol/μl (with an IC<sub>50</sub> of 0.1 pmol/μl) (Gierse <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0015">2010</xref>).</p>
</sec>
<sec id="emmm201505677-sec-0019">
<title>PRG‐1 genotype effect on P50 event‐related potential measures in humans</title>
<p>Study participants were investigated in the context of the German multicenter study “Genetics of nicotine dependence and neurobiological phenotypes”. This study was approved by the ethics committees of each study site's local university and was conducted according to the Declaration of Helsinki and informed consent was obtained from all subjects as described in detail by Lindenberg <italic>et al</italic> (<xref ref-type="ref" rid="emmm201505677-bib-0028">2011</xref>) and Quednow <italic>et al</italic> (<xref ref-type="ref" rid="emmm201505677-bib-0035">2012</xref>). Subjects were healthy as assessed by a standard medical examination, a drug screen, and routine clinical laboratory tests. They had no current psychiatric disorder according to DSM‐IV axis I as assessed by the standardized psychiatric interview (SCID‐1) and were not on any medication affecting CNS function. Across study sites, the study including recordings of EEG was conducted according to the same standard operating procedure.</p>
<p>A detailed description of stimulus presentation (auditory double click paradigm), EEG recording, and signal analysis of the P50 event‐related potential (ERP) has been provided in previous publications (Brinkmeyer <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0005">2011</xref>; Quednow <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0035">2012</xref>). The most widely used P50 measure is the S2/S1 ratio (Turetsky <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0047">2007</xref>). However, recent data suggest that individual S1 and S2 amplitudes as well as the S1‐S2 difference may exhibit higher heritability (Anokhin <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0002">2007</xref>) and superior test–retest reliability than the S2/S1 ratio (Fuerst <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0014">2007</xref>). In view of this lack of superiority of one particular P50 measure over the others, statistical analyses of <italic>prg‐1</italic> genotype effects on P50 ERP measures were performed on S1 and S2 amplitudes, S1‐S2 difference, and S2/S1 ratio.</p>
<p>Genotyping was performed by pyrosequencing according to manufacturer's instructions using the PSQ 96 SNP reagent kit (Qiagen, Hilden, Germany) on a PSQ HS96A instrument (Qiagen, Hilden, Germany). Primer sequences and assay conditions are available on request.</p>
</sec>
<sec id="emmm201505677-sec-0020">
<title>Immunocytochemistry on human tissue</title>
<p>Samples from the somatosensory cortex of a human brain were obtained from routine autopsy in accordance with local ethical committee guidelines. The subject died of non‐neurological causes. Tissue was immersion‐fixed in 4% PFA over 48 h and snap‐frozen on dry ice. Co‐localization studies were performed on cryosections using a PRG‐1 antibody (custom‐made antibody described and characterized by Trimbuch <italic>et al</italic>, <xref ref-type="ref" rid="emmm201505677-bib-0044">2009</xref> was used in a dilution of 1:500) and antibodies against GAD67 (1:500; mab5406, Chemicon), NeuN (1:1,000; mab377, Chemicon), MAP2 (1:1,000; mab 3418, Chemicon), PSD‐95 (1:250, mab1569; Millipore), parvalbumin (1:500; PV235, Swant), and calretinin (1:500; 6B3, Swant). Confocal images were taken on a Leica SP5.</p>
</sec>
<sec id="emmm201505677-sec-0021">
<title>Statistical analysis</title>
<p>For animal experiments, mice from the same litter or of similar age were chosen. The investigator was blinded for the genotype of the animals. Following experiments, experimental results were analyzed, animals were regenotyped, and corresponding final statistical analyses were performed. Briefly, after assessing for normal distribution (using the Kolmogorov–Smirnov test), comparison between two groups, if not otherwise stated, was performed using a two‐tailed unpaired <italic>t</italic>‐test for normal distributed data or a Mann–Whitney <italic>U</italic>‐test for nonparametric data. Comparison between more than two groups was performed using an one‐way ANOVA for parametric data or a Kruskal–Wallis test for nonparametric data. Variances were similar between groups and were estimated using either the <italic>F</italic>‐test or the Brown–Forsythe test and the Bartlett's test. <italic>Post hoc</italic> analysis for more than two groups for parametric data was performed using the Bonferroni adjustment for multiple comparisons and Dunn's test for nonparametric data. For behavioral analyses assessing genotype effects and treatment effects, a 2‐way ANOVA was used. Statistical analyses of data (including testing for normality using the Kolmogorov–Smirnov test) were performed with GraphPad Prism 5/6 (La Jolla, CA, USA) or with SPSS (Chicago, IL, USA).</p>
<p>For statistical analysis of human data, complete datasets including P50 ERP measures and <italic>prg‐1</italic> genotype were available from six study centers for <italic>N</italic> = 1,811 subjects (<italic>N</italic> = 12 monoallelic carriers of the <italic>prg‐1</italic> variant versus <italic>N</italic> = 1,799 wt/wt controls). There were no deviations from Hardy–Weinberg equilibrium (exact test: <italic>P</italic> = 1.0). Major and minor allele frequencies (99.669 and 0.331%, respectively) were consistent with the frequencies reported previously by the NHLBI Exome Sequencing Project. Key sociodemographic sample characteristics are provided in <xref ref-type="supplementary-material" rid="emmm201505677-sup-0001">Appendix Table S1</xref> (Lehrl, <xref ref-type="ref" rid="emmm201505677-bib-0027">1999</xref>).</p>
<p>To avoid confounders such as age, smoking, and study site on P50 ERP measures, we performed a stratified analysis of <italic>prg‐1</italic> genotype effects. For each EEG measure, three strata were determined by predicting for each individual the expected value from a regression model, incorporating age, smoking, and study site, and dividing individuals into distinct, roughly equally sized strata, based on visual inspection of the histograms of predicted values. This model for stratum assignment mainly uses information from the wt/wt controls to control for confounding. In a sensitivity analysis excluding the carriers from model fitting, the results did not change. Subsequently, the standardized mean difference between <italic>prg‐1</italic> wt/wt and monoallelic R345T carriers was determined in each stratum and aggregated over the strata using inverse variance weighting, as commonly used in fixed effect meta‐analysis (Cooper &amp; Hedges, <xref ref-type="ref" rid="emmm201505677-bib-0009">1994</xref>). The assumption of normal distribution, required to obtain p‐values corresponding to the aggregated differences, was checked by Q‐Q plots. For the S1 and S2 combined effect, the standardized mean difference was obtained from a linear mixed‐effects model incorporating a per‐subject random effect. For all other measures, standardized mean differences were directly obtained from mean values and standard deviations, which were calculated separately for the carriers and wt/wt controls, that is, the uneven size of the two groups does not skew the results. Similarly, the linear mixed‐effects models also are not affected by the uneven group sizes. These analyses were performed in the statistical environment R (Team, <xref ref-type="ref" rid="emmm201505677-bib-0043">2011</xref>) using the package “meta” (version 2.1‐0).</p>
</sec>
</sec>
<sec id="emmm201505677-sec-0023">
<title>Author contributions</title>
<p>JV and RN have designed the experiments and have written the paper. JV, SK, HJL, JWY, JH, KR, OT, SG, AS, AM, GW, and RN have contributed to the experimental design and have supervised the experiments and the data analysis. AJM, IT, NF, ST, and UD have performed mass spectrometry analysis. JC, YL, XL, JB, CT, SK, PU, JWY, SR, NS, UD, ST, LQ, KL, OT, HB, NF, IT, AJM, PN, and MRT have been involved in the different experiments. KR and GH have performed the behavioral studies.</p>
</sec>
<sec id="emmm201505677-sec-0024">
<title>Conflict of interest</title>
<p>The authors declare that they have no conflict of interest.</p>
</sec>
<sec id="emmm201505677-sec-0025">
<boxed-text content-type="box" id="emmm201505677-blk-0001" orientation="portrait" position="float">
<caption>
<title>The paper explained</title>
</caption>
<sec id="emmm201505677-sec-0026">
<title>Problem</title>
<p>A mutation (PRG‐1<sup>R345T</sup>) in the human PRG‐1 gene with a monoallelic frequency of ~0.6% affects 5 million European and US citizens and results in an altered signal integration in the central nervous system. We uncovered the underlying molecular signaling pathway at the synapse which involves bioactive lipids controlling basal glutamatergic release in cortical neurons. This pathway is regulated by PRG‐1 which interacts with bioactive phospholipids eventually modulating excitation and signal integration.</p>
</sec>
<sec id="emmm201505677-sec-0027">
<title>Results</title>
<p>Applying molecular, electrophysiological, and behavioral analyses in rodents, we show that PRG‐1<sup>R345T</sup> is a loss‐of‐function mutation, incapable of phospholipid interaction and internalization. Monoallelic loss of PRG‐1 in rodents led to loss of somatosensory filter function and altered resilience during stress‐related behaviors, which are both regarded as an endophenotype for psychiatric disorders. Electrophysiological assessment of monoallelic human PRG‐1<sup>R345T</sup> carriers revealed a similar reduced sensory filter function.</p>
</sec>
<sec id="emmm201505677-sec-0028">
<title>Impact</title>
<p>Using pharmacological intervention into phospholipid signaling, we were able to rescue the altered cortical somatosensory filter function in an animal model with monoallelic PRG‐1 deficiency pointing to a new therapeutic rationale for psychiatric disorders.</p>
</sec>
</boxed-text>
</sec>
<sec sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material content-type="local-data"></supplementary-material>
<supplementary-material content-type="local-data" id="emmm201505677-sup-0001">
<caption>
<p>Appendix</p>
</caption>
<media xlink:href="EMMM-8-25-s001.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="emmm201505677-sup-0002">
<caption>
<p>Expanded View Figures PDF</p>
</caption>
<media xlink:href="EMMM-8-25-s002.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data">
<caption>
<p>Review Process File</p>
</caption>
<media xlink:href="EMMM-8-25-s003.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="emmm201505677-sec-0022">
<title>Acknowledgements</title>
<p>The authors thank Melanie Pfeifer and Nicolai Schmarowski for excellent technical assistance. The studies were funded by the European Research Council (ERC‐AG “LiPsyD”) and the Deutsche Forschungsgemeinschaft (DFG) within the CRC1080 (to RN, JV, IT, JH, HJL, and AS).</p>
</ack>
<ref-list content-type="cited-references" id="emmm201505677-bibl-0001">
<title>References</title>
<ref id="emmm201505677-bib-0001">
<mixed-citation publication-type="journal">
<string-name>
<surname>Albers</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Dong</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>van Meeteren</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Egan</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Sunkara</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>van Tilburg</surname>
<given-names>EW</given-names>
</string-name>, <string-name>
<surname>Schuurman</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>van Tellingen</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Morris</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Smyth</surname>
<given-names>SS</given-names>
</string-name>
<italic>et al</italic> (<year>2010</year>) <article-title>Boronic acid‐based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation</article-title>. <source/>Proc Natl Acad Sci USA
<volume>107</volume>: <fpage>7257</fpage>–<lpage>7262</lpage>
<pub-id pub-id-type="pmid">20360563</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0002">
<mixed-citation publication-type="journal">
<string-name>
<surname>Anokhin</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>Vedeniapin</surname>
<given-names>AB</given-names>
</string-name>, <string-name>
<surname>Heath</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Korzyukov</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Boutros</surname>
<given-names>NN</given-names>
</string-name> (<year>2007</year>) <article-title>Genetic and environmental influences on sensory gating of mid‐latency auditory evoked responses: a twin study</article-title>. <source/>Schizophr Res
<volume>89</volume>: <fpage>312</fpage>–<lpage>319</lpage>
<pub-id pub-id-type="pmid">17014995</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0003">
<mixed-citation publication-type="journal">
<string-name>
<surname>Belforte</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Zsiros</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Sklar</surname>
<given-names>ER</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Quinlan</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Nakazawa</surname>
<given-names>K</given-names>
</string-name> (<year>2010</year>) <article-title>Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia‐like phenotypes</article-title>. <source/>Nat Neurosci
<volume>13</volume>: <fpage>76</fpage>–<lpage>83</lpage>
<pub-id pub-id-type="pmid">19915563</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0004">
<mixed-citation publication-type="journal">
<string-name>
<surname>Brauer</surname>
<given-names>AU</given-names>
</string-name>, <string-name>
<surname>Savaskan</surname>
<given-names>NE</given-names>
</string-name>, <string-name>
<surname>Kuhn</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Prehn</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ninnemann</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Nitsch</surname>
<given-names>R</given-names>
</string-name> (<year>2003</year>) <article-title>A new phospholipid phosphatase, PRG‐1, is involved in axon growth and regenerative sprouting</article-title>. <source/>Nat Neurosci
<volume>6</volume>: <fpage>572</fpage>–<lpage>578</lpage>
<pub-id pub-id-type="pmid">12730698</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0005">
<mixed-citation publication-type="journal">
<string-name>
<surname>Brinkmeyer</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Mobascher</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Musso</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Schmitz</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wagner</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Frommann</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Grunder</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Spreckelmeyer</surname>
<given-names>KN</given-names>
</string-name>, <string-name>
<surname>Wienker</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Diaz‐Lacava</surname>
<given-names>A</given-names>
</string-name>
<italic>et al</italic> (<year>2011</year>) <article-title>P50 sensory gating and smoking in the general population</article-title>. <source/>Addict Biol
<volume>16</volume>: <fpage>485</fpage>–<lpage>498</lpage>
<pub-id pub-id-type="pmid">21392171</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0006">
<mixed-citation publication-type="journal">
<string-name>
<surname>Chang</surname>
<given-names>WP</given-names>
</string-name>, <string-name>
<surname>Arfken</surname>
<given-names>CL</given-names>
</string-name>, <string-name>
<surname>Sangal</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Boutros</surname>
<given-names>NN</given-names>
</string-name> (<year>2011</year>) <article-title>Probing the relative contribution of the first and second responses to sensory gating indices: a meta‐analysis</article-title>. <source/>Psychophysiology
<volume>48</volume>: <fpage>980</fpage>–<lpage>992</lpage>
<pub-id pub-id-type="pmid">21214588</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0007">
<mixed-citation publication-type="journal">
<string-name>
<surname>Cheng</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Hart</surname>
<given-names>GW</given-names>
</string-name> (<year>2001</year>) <article-title>Alternative O‐glycosylation/O‐phosphorylation of serine‐16 in murine estrogen receptor beta: post‐translational regulation of turnover and transactivation activity</article-title>. <source/>J Biol Chem
<volume>276</volume>: <fpage>10570</fpage>–<lpage>10575</lpage>
<pub-id pub-id-type="pmid">11150304</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0008">
<mixed-citation publication-type="journal">
<string-name>
<surname>Cole</surname>
<given-names>RN</given-names>
</string-name>, <string-name>
<surname>Hart</surname>
<given-names>GW</given-names>
</string-name> (<year>2001</year>) <article-title>Cytosolic O‐glycosylation is abundant in nerve terminals</article-title>. <source/>J Neurochem
<volume>79</volume>: <fpage>1080</fpage>–<lpage>1089</lpage>
<pub-id pub-id-type="pmid">11739622</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0009">
<mixed-citation publication-type="book">
<string-name>
<surname>Cooper</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hedges</surname>
<given-names>LV</given-names>
</string-name> (<year>1994</year>) <source/>The Handbook of Research Sysnthesis. <publisher-loc>Newbury Park, CA</publisher-loc>: <publisher-name>Russell Sage Foundation</publisher-name>
</mixed-citation>
</ref>
<ref id="emmm201505677-bib-0010">
<mixed-citation publication-type="journal">
<string-name>
<surname>Coyle</surname>
<given-names>JT</given-names>
</string-name> (<year>2006</year>) <article-title>Glutamate and schizophrenia: beyond the dopamine hypothesis</article-title>. <source/>Cell Mol Neurobiol
<volume>26</volume>: <fpage>365</fpage>–<lpage>384</lpage>
<pub-id pub-id-type="pmid">16773445</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0011">
<mixed-citation publication-type="journal">
<string-name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Mombereau</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Vassout</surname>
<given-names>A</given-names>
</string-name> (<year>2005</year>) <article-title>The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice</article-title>. <source/>Neurosci Biobehav Rev
<volume>29</volume>: <fpage>571</fpage>–<lpage>625</lpage>
<pub-id pub-id-type="pmid">15890404</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0012">
<mixed-citation publication-type="book">
<person-group person-group-type="editor"><name><surname>Davis</surname><given-names>M</given-names></name></person-group> (ed.) (<year>1984</year>) <source/>The Mammalian Startle Response. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Plenum Press</publisher-name>
</mixed-citation>
</ref>
<ref id="emmm201505677-bib-0013">
<mixed-citation publication-type="journal">
<string-name>
<surname>Di Paolo</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Moskowitz</surname>
<given-names>HS</given-names>
</string-name>, <string-name>
<surname>Gipson</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wenk</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Voronov</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Obayashi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Flavell</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Fitzsimonds</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Ryan</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>De Camilli</surname>
<given-names>P</given-names>
</string-name> (<year>2004</year>) <article-title>Impaired PtdIns(4,5)P2 synthesis in nerve terminals produces defects in synaptic vesicle trafficking</article-title>. <source/>Nature
<volume>431</volume>: <fpage>415</fpage>–<lpage>422</lpage>
<pub-id pub-id-type="pmid">15386003</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0014">
<mixed-citation publication-type="journal">
<string-name>
<surname>Fuerst</surname>
<given-names>DR</given-names>
</string-name>, <string-name>
<surname>Gallinat</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Boutros</surname>
<given-names>NN</given-names>
</string-name> (<year>2007</year>) <article-title>Range of sensory gating values and test‐retest reliability in normal subjects</article-title>. <source/>Psychophysiology
<volume>44</volume>: <fpage>620</fpage>–<lpage>626</lpage>
<pub-id pub-id-type="pmid">17437554</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0015">
<mixed-citation publication-type="journal">
<string-name>
<surname>Gierse</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Thorarensen</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Beltey</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Bradshaw‐Pierce</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Cortes‐Burgos</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Hall</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Johnston</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Murphy</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nemirovskiy</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Ogawa</surname>
<given-names>S</given-names>
</string-name>
<italic>et al</italic> (<year>2010</year>) <article-title>A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation</article-title>. <source/>J Pharmacol Exp Therap
<volume>334</volume>: <fpage>310</fpage>–<lpage>317</lpage>
<pub-id pub-id-type="pmid">20392816</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0016">
<mixed-citation publication-type="journal">
<string-name>
<surname>Goswami</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Luderowski</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Vincent</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Rush</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ballif</surname>
<given-names>BA</given-names>
</string-name> (<year>2012</year>) <article-title>Comparative phosphoproteomic analysis of neonatal and adult murine brain</article-title>. <source/>Proteomics
<volume>12</volume>: <fpage>2185</fpage>–<lpage>2189</lpage>
<pub-id pub-id-type="pmid">22807455</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0017">
<mixed-citation publication-type="journal">
<string-name>
<surname>Harrison</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Weinberger</surname>
<given-names>DR</given-names>
</string-name> (<year>2005</year>) <article-title>Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence</article-title>. <source/>Mol Psychiatry
<volume>10</volume>: <fpage>40</fpage>–<lpage>68</lpage>
<pub-id pub-id-type="pmid">15263907</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0018">
<mixed-citation publication-type="journal">
<string-name>
<surname>Hasan</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Nitsche</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Herrmann</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Schneider‐Axmann</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Marshall</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Gruber</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Falkai</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Wobrock</surname>
<given-names>T</given-names>
</string-name> (<year>2012a</year>) <article-title>Impaired long‐term depression in schizophrenia: a cathodal tDCS pilot study</article-title>. <source/>Brain Stimul
<volume>5</volume>: <fpage>475</fpage>–<lpage>483</lpage>
<pub-id pub-id-type="pmid">21945231</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0020">
<mixed-citation publication-type="journal">
<string-name>
<surname>Hasan</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wobrock</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Grefkes</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Labusga</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Levold</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Schneider‐Axmann</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Falkai</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Muller</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Klosterkotter</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Bechdolf</surname>
<given-names>A</given-names>
</string-name> (<year>2012b</year>) <article-title>Deficient inhibitory cortical networks in antipsychotic‐naive subjects at risk of developing first‐episode psychosis and first‐episode schizophrenia patients: a cross‐sectional study</article-title>. <source/>Biol Psychiatry
<volume>72</volume>: <fpage>744</fpage>–<lpage>751</lpage>
<pub-id pub-id-type="pmid">22502988</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0021">
<mixed-citation publication-type="journal">
<string-name>
<surname>Huttlin</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>Jedrychowski</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Elias</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Goswami</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Rad</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Beausoleil</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Villen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Haas</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Sowa</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Gygi</surname>
<given-names>SP</given-names>
</string-name> (<year>2010</year>) <article-title>A tissue‐specific atlas of mouse protein phosphorylation and expression</article-title>. <source/>Cell
<volume>143</volume>: <fpage>1174</fpage>–<lpage>1189</lpage>
<pub-id pub-id-type="pmid">21183079</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0022">
<mixed-citation publication-type="journal">
<string-name>
<surname>Inta</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Monyer</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sprengel</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Meyer‐Lindenberg</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gass</surname>
<given-names>P</given-names>
</string-name> (<year>2010</year>) <article-title>Mice with genetically altered glutamate receptors as models of schizophrenia: a comprehensive review</article-title>. <source/>Neurosci Biobehav Rev
<volume>34</volume>: <fpage>285</fpage>–<lpage>294</lpage>
<pub-id pub-id-type="pmid">19651155</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0023">
<mixed-citation publication-type="journal">
<string-name>
<surname>Javitt</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>Spencer</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Thaker</surname>
<given-names>GK</given-names>
</string-name>, <string-name>
<surname>Winterer</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Hajos</surname>
<given-names>M</given-names>
</string-name> (<year>2008</year>) <article-title>Neurophysiological biomarkers for drug development in schizophrenia</article-title>. <source/>Nat Rev Drug Discov
<volume>7</volume>: <fpage>68</fpage>–<lpage>83</lpage>
<pub-id pub-id-type="pmid">18064038</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0024">
<mixed-citation publication-type="journal">
<string-name>
<surname>Javitt</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>Schoepp</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Kalivas</surname>
<given-names>PW</given-names>
</string-name>, <string-name>
<surname>Volkow</surname>
<given-names>ND</given-names>
</string-name>, <string-name>
<surname>Zarate</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Merchant</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Bear</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Umbricht</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hajos</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Potter</surname>
<given-names>WZ</given-names>
</string-name>
<italic>et al</italic> (<year>2011</year>) <article-title>Translating glutamate: from pathophysiology to treatment</article-title>. <source/>Sci Transl Med
<volume>3</volume>: <fpage>102mr102</fpage>
</mixed-citation>
</ref>
<ref id="emmm201505677-bib-0025">
<mixed-citation publication-type="journal">
<string-name>
<surname>Kalisch</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Muller</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Tuscher</surname>
<given-names>O</given-names>
</string-name> (<year>2015</year>) <article-title>A conceptual framework for the neurobiological study of resilience</article-title>. <source/>Behav Brain Sci
<volume>38</volume>: <fpage>e92</fpage>
<pub-id pub-id-type="pmid">25158686</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0026">
<mixed-citation publication-type="journal">
<string-name>
<surname>Lazarus</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Nam</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sliz</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Walker</surname>
<given-names>S</given-names>
</string-name> (<year>2011</year>) <article-title>Structure of human O‐GlcNAc transferase and its complex with a peptide substrate</article-title>. <source/>Nature
<volume>469</volume>: <fpage>564</fpage>–<lpage>567</lpage>
<pub-id pub-id-type="pmid">21240259</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0027">
<mixed-citation publication-type="book">
<string-name>
<surname>Lehrl</surname>
<given-names>S</given-names>
</string-name> (<year>1999</year>) <source/>Mehfachwahl‐Wortschatz‐Intelleigenztest (MWT‐B), <edition>4th edn</edition>
<publisher-loc>Goettingen</publisher-loc>: <publisher-name>Hogrefe</publisher-name>
</mixed-citation>
</ref>
<ref id="emmm201505677-bib-0028">
<mixed-citation publication-type="journal">
<string-name>
<surname>Lindenberg</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Brinkmeyer</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Dahmen</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Gallinat</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>de Millas</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Mobascher</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wagner</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Schulze‐Rauschenbach</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Grunder</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Spreckelmeyer</surname>
<given-names>KN</given-names>
</string-name>
<italic>et al</italic> (<year>2011</year>) <article-title>The German multi‐centre study on smoking‐related behavior‐description of a population‐based case‐control study</article-title>. <source/>Addict Biol
<volume>16</volume>: <fpage>638</fpage>–<lpage>653</lpage>
<pub-id pub-id-type="pmid">21521423</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0029">
<mixed-citation publication-type="journal">
<string-name>
<surname>Lu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Roche</surname>
<given-names>KW</given-names>
</string-name> (<year>2012</year>) <article-title>Posttranslational regulation of AMPA receptor trafficking and function</article-title>. <source/>Curr Opin Neurobiol
<volume>22</volume>: <fpage>470</fpage>–<lpage>479</lpage>
<pub-id pub-id-type="pmid">22000952</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0030">
<mixed-citation publication-type="journal">
<string-name>
<surname>McDermott</surname>
<given-names>MI</given-names>
</string-name>, <string-name>
<surname>Sigal</surname>
<given-names>YJ</given-names>
</string-name>, <string-name>
<surname>Sciorra</surname>
<given-names>VA</given-names>
</string-name>, <string-name>
<surname>Morris</surname>
<given-names>AJ</given-names>
</string-name> (<year>2004</year>) <article-title>Is PRG‐1 a new lipid phosphatase?</article-title>
<source/>Nat Neurosci
<volume>7</volume>: <fpage>789</fpage>; author reply 789‐790<pub-id pub-id-type="pmid">15280885</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0031">
<mixed-citation publication-type="journal">
<string-name>
<surname>Moolenaar</surname>
<given-names>WH</given-names>
</string-name>, <string-name>
<surname>Perrakis</surname>
<given-names>A</given-names>
</string-name> (<year>2011</year>) <article-title>Insights into autotaxin: how to produce and present a lipid mediator</article-title>. <source/>Nat Rev Mol Cell Biol
<volume>12</volume>: <fpage>674</fpage>–<lpage>679</lpage>
<pub-id pub-id-type="pmid">21915140</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0032">
<mixed-citation publication-type="journal">
<string-name>
<surname>Moremen</surname>
<given-names>KW</given-names>
</string-name>, <string-name>
<surname>Tiemeyer</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nairn</surname>
<given-names>AV</given-names>
</string-name> (<year>2012</year>) <article-title>Vertebrate protein glycosylation: diversity, synthesis and function</article-title>. <source/>Nat Rev Mol Cell Biol
<volume>13</volume>: <fpage>448</fpage>–<lpage>462</lpage>
<pub-id pub-id-type="pmid">22722607</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0033">
<mixed-citation publication-type="journal">
<string-name>
<surname>Munton</surname>
<given-names>RP</given-names>
</string-name>, <string-name>
<surname>Tweedie‐Cullen</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Livingstone‐Zatchej</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Weinandy</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Waidelich</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Longo</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Gehrig</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Potthast</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Rutishauser</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Gerrits</surname>
<given-names>B</given-names>
</string-name>
<italic>et al</italic> (<year>2007</year>) <article-title>Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations</article-title>. <source/>Mol Cell Proteomics
<volume>6</volume>: <fpage>283</fpage>–<lpage>293</lpage>
<pub-id pub-id-type="pmid">17114649</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0034">
<mixed-citation publication-type="journal">
<string-name>
<surname>Pearson</surname>
<given-names>RB</given-names>
</string-name>, <string-name>
<surname>Kemp</surname>
<given-names>BE</given-names>
</string-name> (<year>1991</year>) <article-title>Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations</article-title>. <source/>Methods Enzymol
<volume>200</volume>: <fpage>62</fpage>–<lpage>81</lpage>
<pub-id pub-id-type="pmid">1956339</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0035">
<mixed-citation publication-type="journal">
<string-name>
<surname>Quednow</surname>
<given-names>BB</given-names>
</string-name>, <string-name>
<surname>Brinkmeyer</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Mobascher</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Nothnagel</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Musso</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Grunder</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Savary</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Petrovsky</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Frommann</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Lennertz</surname>
<given-names>L</given-names>
</string-name>
<italic>et al</italic> (<year>2012</year>) <article-title>Schizophrenia risk polymorphisms in the TCF4 gene interact with smoking in the modulation of auditory sensory gating</article-title>. <source/>Proc Natl Acad Sci USA
<volume>109</volume>: <fpage>6271</fpage>–<lpage>6276</lpage>
<pub-id pub-id-type="pmid">22451930</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0036">
<mixed-citation publication-type="journal">
<string-name>
<surname>Radyushkin</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hammerschmidt</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Boretius</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Varoqueaux</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>El‐Kordi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ronnenberg</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Winter</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Frahm</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Fischer</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Brose</surname>
<given-names>N</given-names>
</string-name>
<italic>et al</italic> (<year>2009</year>) <article-title>Neuroligin‐3‐deficient mice: model of a monogenic heritable form of autism with an olfactory deficit</article-title>. <source/>Genes Brain Behav
<volume>8</volume>: <fpage>416</fpage>–<lpage>425</lpage>
<pub-id pub-id-type="pmid">19243448</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0037">
<mixed-citation publication-type="journal">
<string-name>
<surname>Rexach</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Clark</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>Hsieh‐Wilson</surname>
<given-names>LC</given-names>
</string-name> (<year>2008</year>) <article-title>Chemical approaches to understanding O‐GlcNAc glycosylation in the brain</article-title>. <source/>Nat Chem Biol
<volume>4</volume>: <fpage>97</fpage>–<lpage>106</lpage>
<pub-id pub-id-type="pmid">18202679</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0038">
<mixed-citation publication-type="journal">
<string-name>
<surname>Saunders</surname>
<given-names>LP</given-names>
</string-name>, <string-name>
<surname>Cao</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>WC</given-names>
</string-name>, <string-name>
<surname>Albright</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Braddock</surname>
<given-names>DT</given-names>
</string-name>, <string-name>
<surname>De La Cruz</surname>
<given-names>EM</given-names>
</string-name> (<year>2011</year>) <article-title>Kinetic analysis of autotaxin reveals substrate‐specific catalytic pathways and a mechanism for lysophosphatidic acid distribution</article-title>. <source/>J Biol Chem
<volume>286</volume>: <fpage>30130</fpage>–<lpage>30141</lpage>
<pub-id pub-id-type="pmid">21719699</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0039">
<mixed-citation publication-type="journal">
<string-name>
<surname>Shen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Nakamoto</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Pu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kuan</surname>
<given-names>SL</given-names>
</string-name>, <string-name>
<surname>Chatzi</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mackie</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Brandon</surname>
<given-names>NJ</given-names>
</string-name>
<italic>et al</italic> (<year>2008</year>) <article-title>Schizophrenia‐related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1</article-title>. <source/>J Neurosci
<volume>28</volume>: <fpage>10893</fpage>–<lpage>10904</lpage>
<pub-id pub-id-type="pmid">18945897</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0040">
<mixed-citation publication-type="journal">
<string-name>
<surname>Swerdlow</surname>
<given-names>NR</given-names>
</string-name>, <string-name>
<surname>Braff</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Taaid</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Geyer</surname>
<given-names>MA</given-names>
</string-name> (<year>1994</year>) <article-title>Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients</article-title>. <source/>Arch Gen Psychiatry
<volume>51</volume>: <fpage>139</fpage>–<lpage>154</lpage>
<pub-id pub-id-type="pmid">8297213</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0041">
<mixed-citation publication-type="journal">
<string-name>
<surname>Tallent</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Varghis</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Skorobogatko</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hernandez‐Cuebas</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Whelan</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Vocadlo</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Vosseller</surname>
<given-names>K</given-names>
</string-name> (<year>2009</year>) <article-title>
<italic>In vivo</italic> modulation of O‐GlcNAc levels regulates hippocampal synaptic plasticity through interplay with phosphorylation</article-title>. <source/>J Biol Chem
<volume>284</volume>: <fpage>174</fpage>–<lpage>181</lpage>
<pub-id pub-id-type="pmid">19004831</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0042">
<mixed-citation publication-type="journal">
<string-name>
<surname>Tarrant</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Rho</surname>
<given-names>HS</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>YL</given-names>
</string-name>, <string-name>
<surname>Gross</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Culhane</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Qian</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ichikawa</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Matsuoka</surname>
<given-names>T</given-names>
</string-name>
<italic>et al</italic> (<year>2012</year>) <article-title>Regulation of CK2 by phosphorylation and O‐GlcNAcylation revealed by semisynthesis</article-title>. <source/>Nat Chem Biol
<volume>8</volume>: <fpage>262</fpage>–<lpage>269</lpage>
<pub-id pub-id-type="pmid">22267120</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0043">
<mixed-citation publication-type="book">
<string-name>
<surname>Team</surname>
<given-names>RDC</given-names>
</string-name> (<year>2011</year>) <source/>A Language and Environment for Statistical Computing. <publisher-loc>Vienna</publisher-loc>: <publisher-name>R Foundation for Statistical Computing</publisher-name>
</mixed-citation>
</ref>
<ref id="emmm201505677-bib-0044">
<mixed-citation publication-type="journal">
<string-name>
<surname>Trimbuch</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Beed</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Vogt</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Schuchmann</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Maier</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kintscher</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Breustedt</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Schuelke</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Streu</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kieselmann</surname>
<given-names>O</given-names>
</string-name>
<italic>et al</italic> (<year>2009</year>) <article-title>Synaptic PRG‐1 modulates excitatory transmission via lipid phosphate‐mediated signaling</article-title>. <source/>Cell
<volume>138</volume>: <fpage>1222</fpage>–<lpage>1235</lpage>
<pub-id pub-id-type="pmid">19766573</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0045">
<mixed-citation publication-type="journal">
<string-name>
<surname>Trinidad</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Thalhammer</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Specht</surname>
<given-names>CG</given-names>
</string-name>, <string-name>
<surname>Lynn</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Baker</surname>
<given-names>PR</given-names>
</string-name>, <string-name>
<surname>Schoepfer</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Burlingame</surname>
<given-names>AL</given-names>
</string-name> (<year>2008</year>) <article-title>Quantitative analysis of synaptic phosphorylation and protein expression</article-title>. <source/>Mol Cell Proteomics
<volume>7</volume>: <fpage>684</fpage>–<lpage>696</lpage>
<pub-id pub-id-type="pmid">18056256</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0046">
<mixed-citation publication-type="journal">
<string-name>
<surname>Trinidad</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Barkan</surname>
<given-names>DT</given-names>
</string-name>, <string-name>
<surname>Gulledge</surname>
<given-names>BF</given-names>
</string-name>, <string-name>
<surname>Thalhammer</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sali</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Schoepfer</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Burlingame</surname>
<given-names>AL</given-names>
</string-name> (<year>2012</year>) <article-title>Global identification and characterization of both O‐GlcNAcylation and phosphorylation at the murine synapse</article-title>. <source/>Mol Cell Proteomics
<volume>11</volume>: <fpage>215</fpage>–<lpage>229</lpage>
<pub-id pub-id-type="pmid">22645316</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0047">
<mixed-citation publication-type="journal">
<string-name>
<surname>Turetsky</surname>
<given-names>BI</given-names>
</string-name>, <string-name>
<surname>Calkins</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Light</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Olincy</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Radant</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Swerdlow</surname>
<given-names>NR</given-names>
</string-name> (<year>2007</year>) <article-title>Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures</article-title>. <source/>Schizophr Bull
<volume>33</volume>: <fpage>69</fpage>–<lpage>94</lpage>
<pub-id pub-id-type="pmid">17135482</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0048">
<mixed-citation publication-type="journal">
<string-name>
<surname>Turrigiano</surname>
<given-names>G</given-names>
</string-name> (<year>2011</year>) <article-title>Too many cooks? Intrinsic and synaptic homeostatic mechanisms in cortical circuit refinement</article-title>. <source/>Annu Rev Neurosci
<volume>34</volume>: <fpage>89</fpage>–<lpage>103</lpage>
<pub-id pub-id-type="pmid">21438687</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0049">
<mixed-citation publication-type="journal">
<string-name>
<surname>van Winkel</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Stefanis</surname>
<given-names>NC</given-names>
</string-name>, <string-name>
<surname>Myin‐Germeys</surname>
<given-names>I</given-names>
</string-name> (<year>2008</year>) <article-title>Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene‐stress interaction</article-title>. <source/>Schizophr Bull
<volume>34</volume>: <fpage>1095</fpage>–<lpage>1105</lpage>
<pub-id pub-id-type="pmid">18718885</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0050">
<mixed-citation publication-type="journal">
<string-name>
<surname>Wisniewski</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Nagaraj</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Zougman</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gnad</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Mann</surname>
<given-names>M</given-names>
</string-name> (<year>2010</year>) <article-title>Brain phosphoproteome obtained by a FASP‐based method reveals plasma membrane protein topology</article-title>. <source/>J Proteome Res
<volume>9</volume>: <fpage>3280</fpage>–<lpage>3289</lpage>
<pub-id pub-id-type="pmid">20415495</pub-id></mixed-citation>
</ref>
<ref id="emmm201505677-bib-0051">
<mixed-citation publication-type="journal">
<string-name>
<surname>Yizhar</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Fenno</surname>
<given-names>LE</given-names>
</string-name>, <string-name>
<surname>Prigge</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Schneider</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Davidson</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>O'Shea</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Sohal</surname>
<given-names>VS</given-names>
</string-name>, <string-name>
<surname>Goshen</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Finkelstein</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Paz</surname>
<given-names>JT</given-names>
</string-name>
<italic>et al</italic> (<year>2011</year>) <article-title>Neocortical excitation/inhibition balance in information processing and social dysfunction</article-title>. <source/>Nature
<volume>477</volume>: <fpage>171</fpage>–<lpage>178</lpage>
<pub-id pub-id-type="pmid">21796121</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>